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ABSTRACT 
The emergence of benzo[b]thiophenes and benzo[b]furans as biologically useful 
scaffolds is of growing attention in medicine as natural products and pharmaceutical drugs.  The 
means to produce these synthetic cores quickly and from economic starting materials has 
garnered much attention.  Much of the current methodology is focused on formation of the 
heterocyclic ring annulation from benzene derivatives.  However, the mechanistic restraints of 
this chemistry narrows the substitutional scope of the resulting benzo-fused heterocycles.  
Presented here is a simple methodology to produce uniquely substituted benzo[b]thiophenes and 
benzo[b]furans via the intramolecular dehydro-Diels-Alder reaction induced by microwave 
heating.  Starting from aromatic heterocycles and focusing on a strategy of benzene annulation 
from heterocyclic-diene alkynyl-dienophile pairs forming tricyclic fused heterocycles were 
readily synthesized.  The allowance of major product selection was demonstrated by solvent 
choice during heating; fully aromatic heterocycles were favored when PhNO2 was chosen, in as 
little as 10% by volume.  The use of DMF favored the formation of dihydroheterocycles.  The 
reaction showed a tolerance of terminal alkyne substitution and generally produced good yields. 
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 1 
1.0  INTRODUCTION 
The benzo[b]thiophene and benzo[b]furan core in recent decades has come to 
prominence as a promising lead functionality in natural products and pharmaceuticals.  These 
heterocyclic aromatic bicycles are a component of coal tar; however, the imprecise nature of 
aromatic functionalization reactions implicates the demand for late stage annulation of the 
heterocycle moiety.  To this end there has been considerable attention focused on both 
electrophilic induced cyclization and more recently transition metal catalyzed cyclization.  
However, these synthetic processes often impose substitutions on the heterocycle product due in 
part to stability of transition states arising from the particular synthetic technologies.  Recently, 
methodological developments in the microwave-assisted intramolecular dehydro-Diels Alder 
reaction of styrene-yne substrates towards naphthalene derivatives has proven a successful 
approach toward aromatic annulation.  As pursuant to the strategy of aromatic carbocycle 
annulation, it was thought that heterocyclic furan and thiophene could serve as a suitable 
substrate for the microwave-assisted intramolecular dehydro-Diels-Alder reaction towards the 
formation of substituted aromatic benzofused derivatives.  The concerted reaction pathway of the 
[4+2] cycloaddition would allow for an orthogonal methodology versus the more traversed path 
of electrophilic and transition metal cyclizations of the heterocyclic ring. 
 2 
1.1 BENZO[B]THIOPHENE APPLICATION IN DRUG LEADS AND NATURAL 
PRODUCTS 
The benzo[b]thiophene heterocycle core has been shown as a promising lead core 
functionality to a diverse range of approved pharmaceuticals as well as small molecules under 
research development.  These range in activity including antidepressive, anti-inflammatory, 
antifungal, antiviral, dopamine receptor antagonist, and recently recognized as a selective 
estrogen receptor modulator for post-menopausal treatments.  Although the benzo[b]thiophene 
heterocycle functionality is promising as a pharmaceutical scaffold, mimicking the indole 
functionality, though benzo[b]thiophenes have infrequently been described in natural products. 
In 2007 the FDA approved the Eli Lilly Company drug, Raloxifene® 1.01, for use in 
prevention of osteoporosis in post-menopausal woman as an orally active selective estrogen 
receptor modulator.1,2  1.01 may also reduce the risk of invasive 
breast cancer.  The drug, however, does pose a risk to blood-clots 
and as a result, an increase in stroke, though this is not a common 
side-effect.  For this reason, Eli Lily went to develop Arizoxifene, 
a methoxy derivative of 1.01 at the C(2) of the benzo[b]thiophene as an alternative therapy.3  
However, Arizoxifene, failed to meet secondary guidelines in 
clinical studies and FDA approval was not sought. 
A structurally similar compound, 1.02, was found to exhibit 
antimitotic effects.4  1.02, was screened against a variety of cancer 
cell lines such as ovarian, central nervous system, renal, colon, and 
melanoma.  1.02, showed sub-microliter per milliliter inhibitory 
effects on colon cancer cell line KM20L2 and breast cancer cell line MCF7.  The mechanism of 
Figure 1 Raloxifene® 
Figure 2 Antimitotic 2-(4’-
methoxyphenyl)-3-(3’,4’,5’-
trimethoxybenzoyl)-6-
methoxybenzo[b]thiophene 
 3 
Figure 4 Antithrombitic (E)-3-(3-(4-chlorophenoxy)-
5,6-bis((4-(phenylthio)benzyl)oxy)benzo[b]thiophen-
2-yl)-2-(pyridin-4-yl)acrylic acid 
these effects was thought to involve binding to the colchicine binding site of tubulin.  However, 
only modest binding to tubulin was demonstrated by 1.02 when compared to approved 
antimitotics.4 
Sertaconazole, 1.03, is a FDA approved, benzo[b]thiophene containing 
antifungal drug developed by Mylan Lab Incorporated.5  1.03 is effective 
toward a wide range of common pathogenic fungi including Candida albicans, 
Epidermophyton floccosum, and Trichophytons.  Similar to other imidazole 
containing antifungal compounds, 1.03, prevents the synthesis of 
ergosterol, a component of fungal cell membranes.  The benzo[b]thiophene functionality 
mimics indole of tryptophan within the cell membrane proteins and allows a greater 
availability of 1.03 to form pores.5  This mechanism will then cause cell death through cell 
leakage. 
Compound 1.04 has been shown as an antithrombitic agent by De Nantenil et al.6  The 
conversion of plasminogen to plasmin via the tissue type plasminogen activator, t-PA, induces a 
fibrinolytic mechanism and leads to de-clotting by plasmin.  t-PA activity is inhibited by 
plasminogen activator inhibitor-1, PAI-1, in a stable 1:1 protein 
complex.  Elevated concentrations of PAI-1 have been 
correlated with various diseases such as diabetes, obesity, 
coronary artery disease and venous thromboembolism.  
Although, a large benzo[b]thiophene library was 
synthesized, and said compounds were evaluated 
in a t-PA induced fibrin clot lysis assay for the prevention of the t-PA:PAI-1 complex.  1.04, 
was the most effective inhibitor of the t-PA:PAI-1 complex, with an IC50 of 39 nM.
6 
Figure 3 Antifungal 
Sertaconazole 
 4 
Selective 5-HT serotonin reuptake inhibitors, SSRIs, are used as antidepressant 
therapies.7,8  These compounds, however, are not without issues of use such as slow onset of 
effects, lack of consistent response, and other physiological side 
effects such as gastrointestinal intolerance, insomnia, and anxiety.  
Due to these concerns the need for further development of 
antidepressant therapeutic compounds is ongoing.  The activation of 5-
HT1A is thought to play a role in the slow onset effects of the SSRI 
drugs.  Therefore, Takeuchi et al. for Eli Lily developed a library of 
benzo[b]thiophene compounds that would play an antagonistic role 
to impede the 5-HT reuptake sites and 5-HT1A receptor.
7  Examination of structure activity 
relationships showed that all compounds examined showed antagonistic effects of both the 5-
HT and 5-HT1A sites, with the indole functionality effective for the 5-HT1A sites and the 
benzo[b]thiophene functionality effective for the 5-HT reuptake site.7  1.05 showed good 
binding affinities to both the 5-HT and 5-HT1A receptor sites and represents a lead structural 
motif for further study for development of dual-action antidepressant compounds. 
Maintaining the pharmacological theme of dual action SSRI 
compounds Esparza et al. focused on the development of novel 
piperazine based 5-HT reuptake inhibition and 5-HT1A receptor 
antagonist for antidepressant therapies.8  The synthetic design 
followed known compounds which induce serotonin reuptake 
inhibition.  After employing a structure-activity relationship assay of 5-HT1A binding and 5-HT 
transporter binding found that 1.06 exhibited the desired pharmacological profile and represents 
a possible new compound class of dual action SSRI antidepressants.8 
Figure 5 SSRI (S)-1-((R)-4-
(4-methoxybenzo[b]thiophen-
2-yl)-2,2-dimethylpiperidin-
1-yl)-3-((2-methyl-1H-indol-
4-yl)oxy)propan-2-ol 
Figure 6 SSRI 1-
(benzo[b]thiophen-3-yl)-3-(4-(2-
methoxyphenyl)piperazin-1-
yl)propan-1-ol 
 5 
Rho kinases are responsible for effecting intercellular signaling via a monomeric 
GTPase RhoA.  The activation of RhoA enables binding to Rho 
kinases and activates their kinase activity.  However, inhibitors of 
Rho kinases are known to induce many cellular events as 
cytoskeleton remodeling, and relax vascular smooth muscle 
tissue; Rho inhibitors have also been identified to decrease the intraocular pressure and 
therefore perhaps explore the use of Rho kinase inhibitors as a new class of compounds for the 
treatment of glaucoma.9  A benzo[b]thiophene derivative was identified to be an inhibitor of 
Rho kinase 1 and Rho kinase 2.  A structure-activity relationship study was put through 
multiple rounds of inhibitory activity of Rho kinase 1.  1.07 was found to inhibit Rho kinase 1 
and Rho kinase 2 at sub-micromolar levels.  These results prompted in vivo clinical study.  
1.07 was found to have a statistically significant reduction of intraocular pressure in primates 
after an hour of topical eye dosing.9 
The histamine H3 receptor is controlled with the synthesis and release of histamine in the 
body.  The histamine H3 receptor is thought to be a potential 
antagonistic target for a variety of aliments effecting sleeping, 
eating and memory.  Disubstituted phenyl moieties have 
been identified to act as antagonists to the histamine 
H3receptor and for this reason the replacement of the phenyl core by disubstituted aromatic 
heterocycles as a means to further elucidate the structure-activity relationship of the histamine 
H3 receptor.
10  A series of disubstituted benzo[b]thiophenes were synthesized and binding assay 
of the histamine H3 receptor performed.  1.08 was found to be the most efficient and highest 
affinity as a histamine H3 antagonist.  However, in vivo trials were not performed and no 
further study completed.10 
Figure 7 Rho kinase inhibitor 
4-(5-(1-aminobutyl)-3-
methylbenzo[b]thiophen-2-
yl)pyrimidin-2-amine 
Figure 8 Histamine H3 antagonist (4-
cyclobutylpiperazin-1-yl)(3-(piperidin-
1-yl-methyl)benzo[b]thiophen-5-
yl)methanone 
 6 
The benzo[b]thiophene core has seen use in anti-inflammatory drugs and in related 
compounds currently under development.  Leukotrienes are locally acting hormones that are 
mediators in various inflammatory diseases.  They are thought to 
play a role in arthrogenic disease, possibly cancer, and other 
oxidative related ailments.  Leukotrienes are synthesized by 5-
lipoxygenase enzymes, 5-LO, starting with an oxidative 
epoxidation of arachidonic acid.11  Therefore compounds 
which inhibit 5-LO can lead to therapies that address these 
oxidative health issues.  Li, et al. had previously identified a triazole containing 
benzo[b]thiophene scaffold which had an inhibitory effect on 5-LO.  Therefore, a structure-
activity relationship was explored by assessing the inhibition of recombinant human 5-
lipoxygenase, H5-LO, and in the production of leukotriene B4, LTB4.
11  After multiple rounds of 
screening, compound 1.09 was found to be a potent and selective for H5-LO inhibition.11  A key 
attribute to the inhibitory activity of 1.09 is its functional resistance to oxidative conditions.  
1.09 showed good pharmokinetic activity in pre-clinical species and was selected to advance to 
clinical studies. 
Introduced in 1996 by Abbott Laboratories, Zileuton 1.10, is an 
orally active 5-LO inhibitor and suppresses the synthesis of 
leukotrienes.12  1.10 is used as a maintenance drug for the 
treatment of chronic asthma, but is not used for treatment of acute asthma attacks.13  The use of 
Zileuton can have negative side effects such as an increase in liver enzymes, also including 
sleep disturbances and behavioral changes. 
The D3 dopamine receptor has been identified as a playing a role in reinforcing effects 
Figure 9 5-LO inhibitor 3-(4-
fluorophenyl)-6-((4-(1,1,1-trifluoro-2-
hydroxybutan-2-yl)-1H-1,2,3-triazol-1-
yl)methyl)benzo[b]thiophene-2-
carboxamide 
Figure 10 Anti-inflammatory 
Zileuton 
 7 
of the stimulant cocaine.  In recent studies involving curbing the use of cocaine a lead structural 
motif was a pyrazole[1,5a]pyridine-aryl piperazine scaffold.14  
This lead compound displayed a partial antagonism of the D3 
receptor and was thought a logical start in developing a 
structure-activity relationship involve evaluation of similar 
heterocyclic-aryl piperazine compounds.  Compound 1.11 was found to have selective binding 
affinity ratios for D3 receptors versus other dopamine receptors: D2short, D2long, and D4 
receptors.14  1.11 was also found to have a selective binding for the D3 receptor over the 
serotonin receptors 5-HT-1A and 5-HT2.  The N-aryl functionality played a crucial role in the 
antagonistic effect of the D3 receptor.  When the aryl functionality was 2-methoxy-phenyl only 
partial antagonism was observed; while the 2,3-dichloro-phenyl derivative was a potent D3 
receptor antagonist.14  The high selectivity of 1.11 to the D3 receptor and ease of structural 
modification regarding the antagonistic potency of the compounds offers potential scaffolds for 
drug addiction therapies with the partial antagonist derivative and possible antipsychotic for the 
more potent antagonist.14 
Mitsumori et al. reported a prostaglandin D2, PGD2, receptor antagonist based off a 
novel bicyclo[2.2.1]heptane-phenyl sulfonamide structure.15  The 
PGD2 receptor is associated with allergic inflammatory response 
in such conditions as rhinitis, conjunctivitis and asthmas.  These 
compounds demonstrated PGD2 receptor selective antagonism and 
strong inhibitor and lower antagonism toward the PGI2 and TXA2 
receptors.  It was thought that further development could lead to 
possible class of antiallergic drugs.  The ensuing structure-activity relationship began with 
Figure 11 Dopamine D3 receptor 
antagonist N-(4-(piperazin-1-
yl)butyl)benzo[b]thiophene-2-
carboxamide 
Figure 12 PGD2 antagonist 
(Z)-7-((1R,2R,3S,5S)-2-(5-
hydroxybenzo[b]thiophene-
3-carboxamido)-6,6-
dimethylbicyclo[3.1.1]hepta
n-3-yl)hept-5-enoic acid 
 8 
modification of the bicycle-ring system; finding that bicyclo[3.1.1]heptane-amide system was 
a strong antagonist for the PGD2 receptor.
15  Further structural modification identified 1.12 as 
an effective PGD2 antagonist in sub-micromolar concentrations.
15  1.12 was also an effective 
PGD2 antagonist in conjunctive and asthma response in guinea pig models.  These results 
prompted development of 1.12 as a viable compound for an antiallergic drug due to the over 
production of PGD2.
15 
Factor IXa, FIXa, is a vitamin K dependent blood coagulation factor that plays a crucial 
role in the cascade pathway which leads to thrombin formation.16  Thrombin formation is 
accomplished by activation of FXa protease via FX activation; therefore selective inhibition of 
FIXa from the initial activation of the coagulation factor was surmised as 
an approach to development of anticoagulation therapies.  Wang et al., 
starting with a lead 2-amidino-4-iodobenzo[b]thiophene compound 
along with active-site molecular modeling, began a structure-
activity relationship study for the selective inhibition of FIXa versus the FXa enzyme.
16  
Efficiency of the compounds were evaluated through binding assays with FIXa and FXa.  After 
multiple synthetic iterations, altering the position and functionalities of the benzene ring 
component, 1.13 was found to be a strong inhibitor at sub-micromolar levels for FIXa.
16  
However, most compounds analyzed including 1.13, were also shown to be inhibitory toward 
FXa.  Although, 1.13 was not the only compound with such low inhibition concentrations toward 
FIXa, 1.13 was the most selective toward FIXa inhibition versus FXa with over a fifty-fold 
selectivity.16  Though 1.13 is a promising anticoagulant, further research is necessary to elucidate 
a greater selectivity toward inhibition of FIXa. 
Though the benzo[b]thiophene is a promising pharmaceutical-core, the presence of 
Figure 13 Anticoagulant 6-((4-
methoxybenzyl)oxy)benzo[b]thi
ophene-2-carboximidamide 
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benzo[b]thiophene is scarce in natural products.  Koike, et al., have isolated a glycosylated 
benzo[b]thiophene-polycycle.17  Echinothiophene, 1.14, was isolated as yellow needles from the 
roots of Echinops grijissi through n-butyl alcohol extraction and 
methanol crystallization.  The structure of 1.14 was confirmed 
through a combination of IR, HR-FAB MS and one and two 
dimensional NMR studies.  1.14 was observed as a mixture of epimers in methanol at room 
temperature; however, only a single epimer was observed upon recrystallization.  Molecular 
mechanics and dynamics calculations concluded that the isolated epimer was the 
thermodynamically favorable structure.17  The plant material from which 1.14 is isolated has been 
used in traditional Chinese medicine but further medical uses are not reported. 
Angiogenesis, the growth of blood vessels from existing blood vessels, is a crucial 
physiological process in tumor growth.18  Compounds that inhibit angiogenetic behavior may be 
valuable leads for antitumor proliferation.  To this end, Miyamoto, et al., screened acetone 
extracts from marine invertebrates.18  The acetone extract of Watersipora 
subtorquata showed inhibitory effects on bovine aortic endothelial cell, BAEC, 
proliferation.  Isolation of the mixture found bryoanthrathiophene, 1.15, to 
possess inhibitory activity of BAEC proliferation in sub-micromolar 
concentrations.  Although no further assays were preformed, 1.15, does represent a possible 
lead structure for further study in antitumor proliferation pathways from inhibition of vascular 
system growth. 
 
Figure 14 Echinothiophene 
Figure 15 
Bryoanthrathiophene 
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1.2 BENZO[B]FURAN APPLICATION IN DRUG LEADS AND NATURAL 
PRODUCTS 
 
Melatonin is an indole based neurohormone that plays a key role in many physiological 
processes such as sleep/wake cycles, modulation of immune response, and cardiovascular 
system modulation.  These physiological responses are due to antagonism of G-coupled protein 
receptors MT1 and MT2.  Melatonin is equally antagonistic to both receptor sites and is used as 
an over the counter sleep-aid and used for alleviation of jet-lag, its use in more 
serious conditions is not viable due to the fast bodily elimination and 
metabolism.19  In 2005, Takeda Pharmaceuticals North America had ramelteon, 
1.16, approved by the FDA for use as treatment for insomnia.20  1.16 is a 
potent antagonist for MT1 and MT2 binding has half-life 2-3x that of melatonin.
20  1.16 has low 
binding affinity for rGABAA, which is associated with behavioral side effects of other 
insomnia drugs, and shows little potential of abuse.20  Recently, tasimelteon, 1.17, was 
developed by Vanda Pharmaceuticals and approved in 2014, as a drug 
for non-24 hour sleep/wake disorder and other insomnia associated 
disorders.21  1.17 is also a selective MT1 and MT2 antagonist.  Certain 
serious side effects in rodents have been observed with the use of 1.17.21  In an effort to further 
the melatonin-like furan bioisosteres focusing on selective binding of MT1 and MT2, Lesieur, et 
al., carried out a structure-activity relationship study of benzo[b]furan derivatives of 
melatonin.22  Binding assays were performed for both the MT1 and MT2 receptors from 
embryonic kidney cell line HEK260.  The substitution at the C(2) of the benzo[b]furan with the 
Figure 16 Ramelteon 
Figure 17 Tasimelteon  
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phenyl functionality 1.18 proved a nearly ten-fold more potent antagonist toward MT1 and MT2 
receptors than melatonin; no selectivity was reported.22  Alteration of the C(2) of the 
benzo[b]furan with the 3-methoxy-phenyl functionality in 1.18 led to 
excellent selectivity toward MT2 receptor of 123-fold.
22  This selectivity is 
thought to arise from a secondary hydrophobic binding pocket.  Deletion of 
the 5-methoxy group caused a sharp decrease in MT1 and MT2 
receptor binding, and represents a crucial structural role in binding, 
while alterations of the amide chain lowered MT1 and MT2 receptor 
binding slightly.22  It was postulated that amide alteration could tune the selective binding in 
future studies. 
Developing continuous antiviral therapies is of foremost importance to medicinal 
chemists.  Hepatitis C virus is the cause of chronic liver disorders and affects 200 million 
individuals worldwide.  There are millions of new infections 
each year and currently no vaccine exists, although, in recent 
years promising new therapies have emerged.  The RNA-
dependent RNA polymerase NS5B is responsible for the 
synthesis of new viral RNA of the hepatitis C virus.  
GlaxoSmithKline reported development of a boronic acid-
benzo[b]furan pharmacore to inhibit the NS5B activity via allosteric binding at the hydrophobic 
palm II section of the polymerase.23  The NS5B palm II site was chosen to allow the boronic acid 
functionality close proximity to the catalytic-site and thought to affect incoming nucleotide 
triphosphates or the ribose of the RNA strand.  The starting structure was based on the 
discontinued benzo[b]furan hepatitis C pharmaceutical nesbuvir.  1.19 was found to have 
Figure 18 MT1/MT2 
antagonist N-(2-(5-methoxy-
2-arylbenzofuran-3-
yl)ethyl)acetamide 
Figure 19 Hepatitis C NS5B allosteric 
inhibitor (4-((N-(5-cyclopropyl-2-(4-
fluorophenyl)-3-(methylcarbamoyl) 
benzofuran-6-yl)methylsulfonamido 
)methyl)-2-fluorophenyl)boronic acid 
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enzyme IC50 activity of both the hepatitis C wild types 1a and 1b at nanomolar concentrations.
23  
Additionally, 1.19 was found capable of blocking RNA replication, inhibiting NS5B at ten 
micromolar concentrations.23  However, addition of further boronic acid functionalities did not 
improve the antiviral activity. 
Protein tyrosine phosphorylation is a key cellular event involved in biological processes.  
Tyrosine phosphorylation is reciprocally regulated by protein tyrosine kinases, PTKs, and 
protein tyrosine phosphatases, PTPs.24  Alterations to these two protein types have been 
associated with such illnesses as cancer, diabetes, obesity and autoimmune diseases.  Though, 
the targeting of PTKs has led to many approved drugs, PTPs are relatively underexplored.24  Of 
recent interest as an inhibitory target is the lymphoid-specific tyrosine phosphatase, LYP, a 
phosphatase found only in immune cells which functions as a negative regulator of T cell 
receptor signaling pathways.24  Genetic mutations of LYP have shown to be a risk factor for a 
number of serious autoimmune diseases such as type-I diabetes, 
rheumatoid arthritis, Graves disease, lupus erythematosus, etc.  
Mutations of LYP that increase the phosphatase action of the enzyme 
lead to increased inhibition of T/B cell signaling when compared to 
the wild-type LYP.  Further, inactivation or deletion of LYP in 
mice has been shown to produce an immunosuppressive response 
and render protection to type-I diabetes.  Therefore selective 
inhibition of LYP was thought to be viable strategy for addressing autoimmune syndromes.  To 
this end Zhang, et al., began a structure-based lead optimization study to discover a small 
molecule inhibitor of LYP.24  A known issue with the PTP class is the active sites of these 
enzymes are highly conserved with positively charge residues.  Therefore, the task was to 
Figure 20 Protein Tyrosine 
Phosphatase inhibitor 3-((3-
chlorophenyl)ethynyl)-2-(4-(2-
(cyclopropylamino)-2-
oxoethoxy)phenyl)-6-
hydroxybenzofuran-5-
carboxylic acid 
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identify a compound that would be selective for LYP with negatively charged functional 
component yet hydrophobic enough to allow membrane permeability.  Starting with bicyclic 
salicylates as leads and after multiple rounds of LYP binding assays followed by structural 
modification the authors found 1.20 as the most potent LYP inhibitor.  1.20 was found to be a 
potent inhibitor toward LYP, needing only sub-micromolar concentrations.24  Again, with the 
highly conserved active-sties of PTP enzymes, 1.20 was screened for binding potencies with a 
panel of over twenty other PTP enzymes and was nine-fold more selective toward LYP versus 
other PTPs.24  Thus, 1.20 is a potent and selective inhibitor of LYP and serves as an excellent 
basis for further medicinal study in development of small molecule therapies for autoimmune 
related conditions. 
In continuance with pursuing proteins for anticoagulation therapies, Desai et al., targeted 
small molecule inhibition of factor XIa, fXIa.25  Coagulation is induced through multiple protein 
cascades, eventually activating thrombin which leads to clot formation.  fXIa is a homodimer 
serine protease with each sub-unit made up of four domains, A1-A4.  Activation of fXIa converts 
fIX to fIXa and continues the cascade toward thrombosis.25  The targeting of fXIa was of interest 
because fXIa deficient mice grew healthy and did not suffer from hemophiliac type diseases.  
Additionally in hemophilia C, a natural deficiency 
of fXI induces benign bleeding.  Therefore, it was 
surmised that inhibition of fXIa would safely induce 
anticoagulation without severe hemophiliac risk.  
The use of small molecule sulfates was shown to 
induce allosteric inhibition of fXIa.  The authors 
screened 65 sulfonated small molecules as anticoagulation therapies at 300 micromolar 
Figure 21 fXIa allosteric inhibitor sodium 6-ethoxy-
3-(ethoxycarbonyl)-2-(((3-(ethoxycarbonyl)-2-(((3-
(ethoxycarbonyl)-6-methoxy-2-methylbenzofuran-5-
yl)oxy)methyl)-6-methoxybenzofuran-5-
yl)oxy)methyl)benzofuran-7-sulfonate 
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concentrations for reduction of fXIa activity and found that sulfonated benzo[b]furan dimers and 
trimers were the most potent inhibitors.  Further inhibitory screening for fXIa inhibition found 
benzo[b]furan trimer 1.21 to be the most potent inhibitor, active at sub-micromolar 
concentrations.25  It is thought that the allosteric interaction occurs at the A3 domain; more 
specifically at exposed basic lysine/arginine residues via sulfonate interaction which induces 
conformational disruption at the catalytic site.25  Removal of the sulfonate from 1.21 greatly 
reduced the binding efficiency by over 450-fold.25  Interestingly, additional sulfonates did not 
improve the potency of inhibition.  Although no in vivo studies of 1.21 have been performed, it 
does serve as a basis for future structural design of allosteric inhibitors of fXIa as anticoagulation 
therapies. 
Microtubule assembly is essential in cell proliferation and maintenance.  These processes 
are controlled by the protein tubulin via microtubule assembly/disassembly.4  Microtubule 
assembly is also essential in the proliferation of cancer cells, and therefore the targeted inhibition 
of tubulin or microtubule disassembly is of ongoing interest.26  The natural product colchicine is a 
known antimitotic agent acting through tubulin destabilization which blocks mitosis.  However, 
the use of colchicine as an antitumor drug is limited due to serve 
cardiovascular and neurotoxic side effects.  Colchicine derivatives have 
been studied as anticancer leads, yet drug development has not been 
pursued.  Fedorov, et al., have thus set out to synthesize and 
screen colchicine derivatives as antimitotic agents for cancer 
therapies.26  Using molecular modeling, the authors found a key 
structural feature of colchicine and effective derivatives was a non-coplanar ring structure with 
the ability to form hydrogen bonds.26  Multiple polycyclic colchicine derivatives were screened 
Figure 22 Antimitotic N-((7S)-
10-(hydroxymethyl)-1,2,3-
trimethoxy-6,7-dihydro-5H-
benzo[6,7]cyclohepta[1,2-
f]benzofuran-7-yl)acetamide 
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for cytotoxic effects via tubulin binding among HEK923, Jurkat, AsPC-1 cell lines, and 1.22 was 
found to be cytotoxic in sub-micromolar concentrations.26  In a time-resolved turbidity study 
representative of microtubule assembly 1.22 was found to inhibit microtubule assembly at the 
2.5 micromolar level inducing tubulin depolymerization activity.  The in vivo activity of 1.22 
was assessed by injecting 0.4mg/kg once every four weeks in mice inoculated with Wnt-1 breast 
tumor cells.  1.22 inhibited tumor growth while no weight loss, neurological, or behavioral 
changes were observed.26  1.22 shows high cytotoxicity through tubulin binding disrupting cell 
cycle proliferative activity.  In vivo tumor inhibition was also observed in mice with few adverse 
side effects.  Thus, 1.22 is a promising lead for further study as an antitumor therapy. 
The benzo[b]furan structure is ubiquitously found in natural products due to the 
abundance of tyrosine and phenylalanine as synthetic feed stocks.  Benzo[b]furans are 
continually discovered in natural materials and many show promise for further study both 
medicinally and in structural leads.  Kadota, et al., isolated novel benzo[b]furan derivatives from 
Brazilian propolis.27  Propolis is a resinous hive substance produced by honeybees.  Propolis has a 
known therapeutic use in traditional medicines and has been 
reported to possess properties such as anticancer, antioxidant, 
antifungal and antibiotic.  Recently, propolis has gained 
popularity as a health food; ingesting the resin is purported to 
prevent inflammation, heart disease, and diabetes.27  Extraction of the propolis with methanol 
showed cytotoxicity toward liver-metastatic murine colon 26-L5 carcinoma and human HT-1080 
fibrosarcoma cells.  These results prompted isolation of the constituents of the material.  1.23 
was isolated from the methanol solutions of the Brazilian propolis and identified with IR, HR-
FAB MS, and NMR experiments.  1.23 was found to exhibit moderate cytoxicity toward liver-
Figure 23 Cytotoxic ((2R,3S)-5-(6-
acetyl-5-hydroxybenzofuran-2-yl)-2-
(3-hydroxy-4-methoxyphenyl)-3,4-
dihydro-2H-pyran-3-yl)methyl acetate 
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metastatic murine colon 26-L5 carcinoma and human HT-1080 fibrosarcoma cells with and ED50 
values of 12.4 g/mL and 13.9 g/mL.27  Though 1.23 is not as medicinally active as hoped, it 
serves as a pharmaceutical structural lead for further study. 
The roots of the Krameria lappacea are used for oropharyngeal inflammation in 
traditional medicines from South America.28  These roots have also been used in early-modern 
Europe as a remedy for stomachache, diarrhea, nose bleeds, and inflammation of the mouth.  
Previous studies show the constituents of K. lappacea have 
potential as anti-inflammatory therapies.  Therefore, isolation 
and identification of the root material constituent compounds 
was undertaken and examined for inflammatory properties by 
Stuppner et al.  1.24 was isolated from dichloromethane extraction, and its structure elucidated 
by HR-FAB MS and NMR.28  Activity of 1.24 as an anti-inflammatory agent was assessed 
through topological administration and binding assays of key intermediates of inflammation-
inducing pathways.  Topical administration of 1.24 at sub-micromolar concentrations reduced 
edema formation near completion after induced dermatitis in mice.28  Microscopic analysis of the 
tissue showed a reduction of dermal swelling and reduced blood vessel dilation similar to that of 
the control tissue.  To attempt to elucidate the direct mechanism of anti-inflammatory activity 
1.24 was screened for binding activities for a number of known inflammation inducing enzymes.  
1.24 was found to inhibit NF-B activation at low micromolar concentrations.28  1.24 also showed 
significant inhibition of 5-lipoxygenase in leukotriene formation, active at low micromolar 
concentrations.  1.24 showed free radical scavenging activity at low micromolar concentrations.  
In a 2,2-diphenyl-1-picrylhydrazyl assay, 1.24 had equal scavenging potential to that of the 
standard, ascorbic acid.28 
Figure 24 Anti-inflammatory 2-(5-(3-
hydroxypropyl)benzofuran-2-yl)-5-
methoxyphenol 
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The Zanthoxylum wutaiense is an evergreen shrub native to Taiwan.  Methanol extracts 
of Z. wutaiense root wood were screened for antitubercular activity against 
Mycobacterium tuberculosis H37Rv cell line which lead Chen et al., to 
isolate and elucidate the compounds in the methanol extract and 
verify their individual activities.29  The authors were able to isolate 
six benzo[b]furan natural products from the extracts.  In a minimum inhibition concentration 
assay of Mycobacterium tuberculosis, H37Rv 1.25 was found to be the most potent inhibitor at 
35 micrograms per milliliter.29  Though this is five times higher than the control, ethambutol, it 
does represent a structural lead for further development of antitubercular drugs. 
The ability for cells to respond to low cellular concentrations of oxygen is mediated by 
hypoxia-inducible factor 1, HIF-1.30  The production of HIF-1 is coupled to the protein, vascular 
endothelial growth factor, VEGF, which induces vascular tissue growth in low oxygen tissues 
and is observed in hypoxia tumor cell proliferation.30  HIF-1 is stabilized under low oxygen 
concentrations and overexpression is known to cause tumor cell proliferation and be a resistance 
factor in radio/chemotherapies.  Lee et al., in an effort to discover natural product HIF-1 
inhibitors screened a series of plant extracts for inhibitory activity.30  Chloroform extracts of the 
Morus bombysis showed inhibitory effects on HIF-1 due to low 
oxygen concentrations.  To identify the HIF-1 inhibitory activity of 
the chloroform extract the authors isolated and identified the 
individual small molecule constituents.  Four benzo[b]furan compounds were isolated belonging 
to the moracin natural product family.  1.26, moracin O, was found to be the most potent 
inhibitor of HIF-1 in human hepatocellular carcinoma Hep3B cells, inducing IC50 inhibition in 
nanomolar concentrations.30  Complete inhibition was observed at thirty micromolar 
Figure 25 Antitubercular (E)-3-
(7-methoxybenzofuran-5-
yl)acrylaldehyde 
Figure 26 HIF-1 inhibitor 
Moracin O 
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concentrations.  Moracin P also showed similar concentration of inhibition.  1.26 measured 
effective in micromolar concentrations to limit the secretion of VEGF in the Hep3B cells in an 
ELISA assay.  1.26 represents a promising approach to HIF-1 inhibition and a lead molecule 
toward hypoxia tumor therapies. 
 19 
2.0  BENZO[B]THIOPHENE AND BENZO[B]FURAN SYNTHETIC 
CONSTRUCTION METHODS 
The construction of the benzo[b]thiophene and benzo[b]furan cores have seen much 
attention by synthetic chemists.  Starting from pre-functionalized benzene derivatives and 
concentrating on heterocyclic ring formation has been the lingua franca of strategies employed 
to date.  Heterocyclic annulation has equally employed both classical electrophilic cyclization 
mechanisms and, recently, transition metal catalysis.  However, these reaction schemes, due to 
the mechanistic constraints, routinely yield highly substituted benzo[b]thiophenes and 
benzo[b]furans, namely at the C(2) and C(3) of the benzofused heterocycles. 
 
2.1 BENZO[B]THIOPHENE SYNTHETIC CONSTRUCTION METHODS 
The tool kit of organic synthesis has an unrealizable debt owed to the utility and scope of 
transition metal carbon-carbon cross coupling reactions. Palladium catalyzed reactions have 
allowed access to products that traditional organic reactions could not achieve without penalty of 
low yields, mixtures or economically unsuitable conditions.  The Pd-catalyed C-S bond 
formation allows for simple thiophenol starting substrates which then limits deviation to 
unwanted byproduct formation. 
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Lautens, et al. developed a Pd catalyzed tandem C-S thiophene formation followed by 
Suzuki reaction for C(2) substitution.31  Starting with simple othro gem-dihalovinyl thiophenol, 
2.01, and 3% Pd SPhos catalyst formed first the intermediate 2-bromo-benzo[b]thiophene which 
was followed by in situ Suzuki arylation with a suitable boronic acid.  The reaction required a 
temperature of 110 °C in dioxane and multiple 
equivalents of base but proceeded in very good yields, 
91%-82%, of aryl-2-benzothiophenes, 2.02, from both 
electron withdrawing and electron donating aryl 
boronic acids.31  The authors found that the reaction 
was compatible with boronic acids but also boronic esters, trifluoroborate salts, and alkyl 
boranes as Suzuki coupling agents; all proceeding to the benzo[b]thiophene products in good 
yields. 
To widen the substrate scope of this Pd catalyzed tandem C-S bond formation followed 
by Suzuki reaction, examination of substitution effects on the gem-dihalovinyl thiophenol, 2.03, 
was undertaken.  Substitutions of the 
thiophenol greatly impacted the 
outcome.31  4-Fluoro, 3-chloro and 4-
methyl substitutions to the thiophenol 
produced good yields of the corresponding benzo[b]thiophene product, 2.04.  Surprisingly, the 4-
bromo and 5-bromo derivatives produced dual arylated benzo[b]thiophenes under reaction 
conditions, forming three bonds rather than two in good yields.  4,5-Methylenedioxy and 6-
trifluoromethane both produced the C(2) arylated benzo[b]thiophene product in markedly lower 
yields.  The 4-nitro thiophenol successfully underwent C-S bond formation but did not undergo 
Figure 27 Pd catalyzed tandem thiophene 
annulation/Suzuki coupling of ortho geminal-
dihalovinyl thiophenols boronic acid variation 
Figure 28 Pd catalyzed tandem thiophene annulation/Suzuki 
coupling of ortho geminal-dihalovinyl thiophenols variation 
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the subsequent Suzuki coupling.  Finally, the authors showed that the Pd catalyzed C-S bond 
formation of the thiophenol substrate was also compatible with both Heck and Sonogashira 
tandem couplings.31 
Transition metal carbeniods have been employed to achieve a number of highly 
chemoselective synthetic transformations including cyclopropanations, nucleophilic insertions 
and metathesis reactions; Yin, et al. set out to explore the use of palladium catalyzed metal 
carbenoids in heterocyclic ring forming reactions 
from simple 2-iodo thiophenols.32  The highly 
reactive Pd carbenoid intermediate was thought 
accessible through a 2-furyl diazoalkanes.  However, 
due to inherent instability and toxicity of these 
species, the 2-furyl diazoalkanes were best accessed 
via deprotonation of the proceeding stable furfural tosylhydrazone followed by decomposition to 
the diazo substrates.32  After an extensive optimization screening the authors found that the ideal 
catalyst was five molar percent of 1,1´-bis(diphenylphosphino) ferrocene palladium in toluene at 
100 °C with excess base.  Using 2-iodo thiophenols and furfural aryl tosylhydrazone, 2.05, the 
authors were able to achieve moderate yields of 2,3-substituted benzo[b]thiophenes, 2.06.  Jiang 
proposed the product formation proceeds through a number of key intermediates.32  After the 
initial oxidative insertion of the 2-iodo thiophenol to the Pd center, the 2-furyl diazoalkane is 
complexed forming a Pd carbenoid species.  An aryl migratory insertion at the carbenoid carbon 
affords a methylenepalladium halide.  This is followed by allene formation via furan ring 
opening, the sulfur then nucleophilicly attacks the sp carbon thus forming the heterocycle.32  After 
Pd catalyst decomplexation, the benzo[b]thiophene, 2.06, is formed. 
Figure 29 Benzo[b]thiophene synthesis via Pd 
catalyzed cross-coupling of furfural 
tosylhydrazones and  2-iodo thiophenol 
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Gabriele et al., described a convenient and versatile method to convert simple 2-
substituted thiophenols to 2,3-substituted benzo[b]thiophenes using a PdI2 catalyst.
33  Starting 
with simple C(2) substituted aldehyde or ketone, thiophenols, 2.07, are first converted to a 
propargylic alcohol via nucleophilic alkynyl Grignards.  With the alkynyl moiety, 2.08, installed 
it was found that as little of two molar percent of PdI2 with KI co-catalyst at 80 °C in acetonitrile 
could initiate the nucleophilic 5-exo-dig attack of the sulfur and thus create the heterocycle.33  
After dehydration, the 
product is decomplexed 
from the catalyst to 
generate 2,3-substituted 
benzo[b]thiophenes, 2.09.  The reaction showed tolerance for methyl and phenyl ketones, as well 
as aldehydes in the 2-carbonyl thiophenol starting materials, however, discrepancies were seen 
for the more sterically bulky alkynes.33  Alkyl and phenyl alkynes produced moderately good 
yields of 70%-82%, however, when benzyl alkynes were employed the yields fell to 56%.  This 
methodology employed a simple installment of alkynes to 2-carbonyl thiophenol and PdI2 
catalyzed heterocyclization. 
Reddy, et al., have developed a method of substituted benzo[b]thiophenes construction 
via benzene annulation via 
Suzuki coupling followed 
base promoted [4+2] 
cyclization.34  The 
unsaturated 2.11 substrate 
is first coupled with an aryl heterocycle, 2.10, via Suzuki reaction using five molar percent 
Figure 30 Benzo[b]thiophene synthesis via Pd catalyzed heteroannulation and 
aromatic dehydration of 1-(2-mercaptophenyl)-2-yn-1-ol 
Figure 31 Pd catalyzed Suzuki cross-coupling and base promoted benzene 
annulation to substituted benzo[b]thiophenes 
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Pd(OAc)2 in refluxing acetonitrile.  In the presence of nitrogenous base, the newly formed 
benzylic carbon is deprotonated and the resulting intermediate undergoes a 6-exo-dig 
annulation.34  The newly formed carbocycle then undergoes a 1,7-proton shift and thus 
rearomatizes forming a benzo[b]thiophene core, 2.12a/b.  Using C(2) and C(3) thiophene 
boronic acid, 2.10, led to comparable yields of 68% and 73% of benzo[b]thiophene product. 
Pushing the substrate scope further, when sterically bulky (5-acetylthiophen-3-yl)boronic acid as 
a Suzuki reagent, the benzo[b]thiophene adduct was isolated in 70% yield.34 
Although many Pd catalyzed benzo[b]furan and indole methodologies exist starting from 
ortho-alkynyl phenols and anilines the same 
methodology is not applicable when attempting 
benzo[b]thiophene formation due to catalyst poisoning 
from the sulfur.  Due to the simplicity of the starting 
material construction and the need for a reliable catalytic 
method of benzo[b]thiophene construction from said 
starting materials, Nakamura et al., embarked on studies to cyclize ortho-alkynyl thiophenols, 
2.13, to the corresponding benzo[b]thiophenes, 2.14.35  After screening a number of transition 
metal catalysts it was found that as little as two molar percent of AuCl induced the cyclization of 
o-alkynyl sulfide 2.13 at room temperature to generate 2,3-substituted benzo[b]thiophene 2.14 in
high yield.35  The reaction showed compatibility with electron-withdrawing and electron-donating 
aryl alkynes, as well as alkyl alkynes.  The authors suggested the gold catalyst first activates the 
alkyne to nucleophilic sulfur attack and heterocycle formation.  The intermediate then undergoes 
a alkyl migration from the sulfonium ion to the C(3), which then decomplexes with the gold 
catalyst and forms the 2,3-subsutituted benzo[b]thiophenes.35  This methodology is very 
Figure 32 Au catalyzed heteroannulation 
and sulfonium rearrangement to 
benzo[b]thiophenes 
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promising due to the ease of starting material construction, low catalyst load, mild reaction 
conditions and very high yields of 2,3-subsutituted benzo[b]thiophenes products. 
An iridium catalyzed hydrogen transfer of ortho-benzylic alcohol sulfides, 2.15, has been 
developed which then undergoes heterocycle annulation under basic conditions.36  It is known that 
iridium complexes are potent hydrogen transfer catalysts which could be employed to induce 
oxidation an aryl alcohol to the corresponding aldehyde, 2.15.  The screening of iridium 
complexes showed the [IrCp*Cl2]2 complex was most competent at hydrogen transfer.
36  
However, a fully hydrogenated heterocycle byproduct was observed, therefore, the optimized 
conditions employed 2.5 
molar percent of Ir 
catalyst with 
stoichiometric amount of 
cesium carbonate base and p-benzoquinone as oxidizing agent for reduced iridium species.36  Of 
note is the differentiation of yields with variation of electron withdrawing groups of the sulfide, 
2.15.  When an alpha ester sulfide moiety was employed the thiophene cyclization proceeded in 
a high yield of 93%, 2.17.36  However, when an alpha nitrile sulfide moiety was employed the 
yield dropped dramatically to 40% product formation, 2.17.36  This can be rationalized by the 
lower acidity of the alpha proton of the nitrile functionality versus that of the carbonyl. 
Recently, Zhang et al., developed a copper catalyzed method of benzo[b]thiophene 
heterocycle annulation via tandem C-S bond formation from 2-bromo alkynylbenzenes, 2.18, and 
sodium sulfide.37  The methodology is significant due to the economical starting materials and 
catalyst.  The thiophene annulation was precedented by Takimiya via heating at 180 °C in NMP 
using the 2-bromo alkynylbenzenes and sodium sulfide.37  The need to improve this previous 
Figure 33 Ir catalyzed benzylic alcohol oxidation and base promoted aromatic 
dehydration to substituted benzo[b]thiophenes 
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methodology to lower reaction temperatures prompted interest in a catalytic means of 
accomplishing the hetero-annulation.  Primary investigation of simply heating starting materials 
in DMF to 80 °C in the absence of catalyst produced 
low yield of the desired product, which concluded 
that high reaction temperatures were required to 
obtain benzo[b]thiophene products.37  A thorough 
screen of copper salts, solvent, reaction 
temperatures, catalyst ligands and catalyst loading 
found 10 molar percent CuI with tetramethyl ethylenediamine ligand while heating in DMF to 80 
°C converted 1-bromo-2-(phenylethynyl)benzene, 2.18, to 2-phenylbenzo[b]thiophene in 83%, 
2.19.37  With optimized conditions in hand, a substrate screening was carried out to understand 
the tolerance of the reaction.  Variations of the aryl functionality of the alkyne terminus 
commenced.  Mildly electron donating phenyls: methyl, methoxy, and chloro, proved 
comparable to the model system; all producing good yields of 71%-82%, 2.19.  Heterocyclic 
thiophene and pyridine alkynyl substrates conveniently underwent the reaction in good yields of 
73% and 70%.  However, various electron poor aryls (trifluoromethyl, aceto, and nitrile) 
significantly lowered the product yields to 48%-54%.  The reaction proved very sensitive to 
sterically demanding substrates; both isopropyl and biphenyl functionalities on the alkyne 
terminus gave no reaction in the first instance and only trace product in the second.37  The 
reaction showed compatibility when multiple substituted 2-bromo-alkynylbenzenes were 
explored as substrates.  2-Bromo-4-methyl-1-(phenylethynyl)benzene derivatives proved 
successful in undergoing the annulation reaction.  Of note is the use of 2-bromo-4-halo-1-
Figure 34 Cu catalyzed benzo[b]thiophene 
synthesis via dual C-S bond formation from 2-
bromo alkynylbenzenes and and sodium sulfide 
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(phenylethynyl)benzene derivatives of fluorine and chlorine not only successfully underwent 
product formation but also maintained 6-halo substitution without incident.37 
Building on catalytic copper C-S bond formation, Ila, et al., focused on a strategy of 
C(7)-S(1) bond formation from a thioenolate intermediate, yielding 2,3-substituted 
benzo[b]thiophenes, 2.23, in high yields.38  The authors envisioned the thiophene ring could be 
formed in a tandem fashion, first, C(2)-C(3) bond formation by base induced condensation of 
dithioester, 2.21, and 2-bromo-arylacetonitrile, 2.20, resulting in intermediate enethiolate, 2.22. 
The enethiolate 
intermediate 
would then 
undergo Cu catalyzed 
C(7)-S(1) bond 
formation completing the annulation reaction and forming the benzo[b]thiophene product, 2.23.38  
2-Bromo-5-methoxyphenylacetonitrile and 4-methoxyphenyl dithioester were used as model 
starting materials to explore optimized reaction conditions.  After determining NaH was best 
suited for condensation to the sodium enthiolate intermediate, the screening of intramolecular C-
S coupling conditions found the use of 10 molar percent of CuI and L-proline at 90 °C in DMF 
produced the 5-methoxy-3-nitrile-2-(4-methoxyphenyl)benzo[b]thiophene in 90% yield.38  The 
subsequent substrate scope study displayed an extremely high tolerance to a plethora of aryl 
dithioesters, 2.21, bearing electron donating/withdrawing, and sterically demanding aryl and 
heteroaryl moieties producing substituted benzo[b]thiophenes, 2.23, in good yield.38  The reaction 
conditions also proved compatible with dimethyl trithiocarbonate, dithiocarbonate, and 
isothiocyanate as the thiocarbonyl component producing the 3-nitrile-2-hetero-
Figure 35 Base promoted enethiolate formation from 2-bromo-arylacetonitriles and 
Cu catalyzed heteroannulation to substituted benzo[b]thiophenes 
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benzo[b]thiophenes in excellent yields, 80%-93%.  The above conditions show a high scope of 
substrate compatibility, high yielding product formation, economical reaction conditions in the 
formation of synthetically useful 2,3-benzo[b]thiophenes.38 
Few synthetic transformations can compare to the reliability and functional tolerance of 
the Wittig reaction in construction of carbon-carbon double bonds.  By virtue of these traits Lin 
et al., studied the construction of 2,3-disubstituted 
benzo[b]thiophenes, 2.26, via intramolecular 
carbon double bond formation from 2-
benzaldehyde thioesters, 2.24.39  The strategy 
centered on 1,2 addition of phosphine to aryl 
aldehydes, 2.24, followed by in situ trapping of the phosphonium oxide zwitterion intermediate 
via acylation.  The trapped intermediate then undergoes base-induced Wittig reaction with the 
thioester sub-moiety, yielding the disubstituted benzo[b]thiophene product, 2.26.  The optimized 
conditions use tributylphosphine in slight stiochemetric excess, heating with S-(2-formylphenyl) 
benzothioate, 2.24, in THF at 50 °C in the presence of triethyl amine and benzyol chloride, 
2.25.39  These conditions produced the desired 2-phenylbenzo[b]thiophen-3-yl benzoate in 
moderate 58% yield, 2.26.  Of note is the interesting C(3) oxy-substitution which in of itself is a 
unique functional pattern rarely observed in benzo[b]thiophene constructions.  Moving to 
explore the substrate scope, the authors varied the thioester, 2.24, as well as the acid chloride, 
2.25. 2-chloro, 3-chloro, and 4-chloro aryl groups produced comparable yields to that of the 
phenyl substrate.  Note that the more sterically demanding 2-chloro aryl substrate produced the 
lowest conversion to the benzo[b]thiophene product, 2.26.39  When 4-bromo and 2-bromo aryl 
derivatives were employed the trend remained.  The 4-bromo derivative, again, produced the 
Figure 36 Substituted benzo[b]thiophene 
synthesis via intramolecular Wittig olefination of       
2-benzaldehyde thioesters 
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moderate yield of 51%.  The steric effect of the larger bromine atom at the 2-position decreased 
the product yield to only 17%.  Poor yields were also observed with the use of heterocyclic 2-
furyl and alkyl iso-butyl derivatives only producing the benzo[b]thiophenes, 2.26, in 23% and 
42%.39  The methodology here describes a straightforward manner in which to create uniquely 
substituted benzo[b]thiophenes, 2.26, although in moderate yields and sees sterically demanding 
substrates diminish the product conversion. 
Building on the use of the Wittig reaction as a reliable means to install the C(2)-C(3) 
double bond of the heterocycle, Yu et al., employed a copper catalyzed C-S bond formation 
followed by Wittig reaction.40  Although the reaction follows a parallel strategy of bond 
formation, the substrate employed is a 2-iodobenzyl phosphonium bromide salt, 2.27, allowing 
for simple and economic starting 
materials for the conversion of 
benzo[b]thiophenes products, 2.29.  
The critical installation of the sulfur 
atom was to be sourced from 
thiobenzoic acid, 2.28.  Using (2-iodobenzyl) phosphonium bromide, 2.27, and thiobenzoic acid, 
2.28, as model substrates, screening found optimized conditions of five molar percent of CuI, 
1,10-phenanthroline as ligand and stoichiometric excess of tri-n-propyl amine in dioxane at 100 
°C.40  These conditions successfully produced 2-phenyl benzo[b]thiophene, 2.29, in 87%.  Using 
the optimized conditions, the scope of the reaction substrates were studied.  Various substitutions 
of the phosphonium bromide salt, 2.27, including electron donating and electron withdrawing 
groups showed little effect on the yield of the benzo[b]thiophene products, 2.29.40  Of note, the 
use of secondary alkyl phosphonium salt resulted in no desired heterocycle product.  The 
Figure 37 Cu catalyzed C-S bond formation of thiocaboxylic 
acids to 2-iodobenzyl phosphonium salts and intramolecular 
Wittig olefination to substituted benzo[b]thiophenes 
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substitution of the thioaryl acids, 2.28, resulted in good yields of benzo[b]thiophene products 
67%-81%; with the lone exception of the electron withdrawing 4-chloro-thiobenzoic acid, which 
gave trace amount of product.40  The use of 2-thiophene thiocarboxylic acid and of 2-furan 
thiocarboxylic acid produced the 2-heterocyclic-benzo[b]thiophenes in 63% and 74%.  The 
reaction methodology was even compatible with the use of the aliphatic thiophenylacetic acid 
and thioacetic acid yielding 2-alkyl benzo[b]thiophenes in 60% and 40%. 
In a divergence from metal catalyst methods for heterocycle annulation reactions 
benzo[b]thiophenes have been prepared through traditional electrophilic induced cyclization as 
well as newly reported radical induced cyclization.  Konig, et al., were the first to report a 
photocatalytic synthesis of benzo[b]thiophenes, 2.32, from ortho-diazonium methyl sulfides, 
2.30, through a radical annulation 
pathway.41  The author previously report 
aryl substitution of benzo[b]thiophenes 
starting from aryl diazonium salts and 
benzo[b]thiophene via photocatalyst and 
visible light.41  Although the strategy conceptually proved successful, it was mired by poor 
yields and product mixtures of 2-aryl-benzo[b]thiophenes and 3-aryl-benzo[b]thiophenes.  
Building on this strategy, the authors surmised that photocatalytic heterocycle annulation via 
ortho-diazonium methyl sulfides, 2.30, with alkynes, 2.31, could potentially offer more reliable 
means to construct substituted benzo[b]thiophenes, 2.32.  To determine optimized reaction 
conditions phenyl acetylene, and 2-(methylthio)benzenediazonium were screened through 
various conditions.  It was found the use of five molar percent of eosin Y as photoredox catalyst 
under 530 nm LED light in DMSO successfully induced the annulation, producing 2-phenyl-
benzo[b]thiophene, 2.32, in 75% and without any C(3) substituted isomer.41  Proving the crucial 
Figure 38 Visible light catalyzed benzo[b]thiophene synthesis 
from 2-(methlythio)benzene diazonium salts and phenyl 
acetylenes 
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role of all reaction components, when the reaction was performed without light or eosin Y, only 
trace amounts of the product were isolated.  With optimized conditions in hand, the breadth of 
the substrate scope was examined.  Keeping phenyl acetylene, 2.31, as the radical coupling 
partner, various aryl substitutions on the ortho-diazonium methyl sulfide, 2.30, were explored.  
Alkyl, halo, and alkyloxy functionalities at 
the C(4) or C(5) position of the ortho-
diazonium methyl sulfide, 2.30, proved 
compatible to annulation conditions, 
producing the desired benzo[b]thiophenes 
in good yields of 62%-76%.41  Alternatively, substituting the alkyne, 2.31, with a variety of 
electron withdrawing and electron donating phenyl derivatives yielded benzo[b]thiophenes, 
2.32, in comparable yields, 62%-81%.41  Only when using n-butyl acetylene and trimethylsilyl 
acetylene did the reaction yield poor results, producing the 2-n-butyl-benzo[b]thiophene in 30% 
and the 2-trimethylsilyl-benzo[b]thiophene in slightly better 45%.  Switching from terminal 
alkynes to 1,4-diesters alkynes, 2.34, gave moderate yields of 2,3-dicarboxylate 
benzo[b]thiophenes, 2.35, 40%-61%.41  The dimethyl esters proved slightly higher yielding 
than the diethyl esters, presumably due to the larger steric bulk of the ethyl component.  In an 
effort to understand the mechanistic pathway, the authors doped the reaction of phenyl 
acetylene and 2-(methylthio)benzenediazonium with TEMPO to attempt the capture of radical 
intermediates.  Two TEMPO adducts were found, the first indicating the radical disassociation 
of C-N2
+ 
aryl bond, and the second, from a vinyl radical after the aryl radical alkyne coupling.  
It was proposed the vinyl radical then couples to the sulfur atom which undergoes oxidation via 
the redox catalyst and forms the benzo[b]thiophene product.41 
Figure 39 Visible light catalyzed benzo[b]thiophene 
synthesis from 2-(methlythio)benzene diazonium salts and 
internal alkynes 
 31 
Using simple means to construct synthetically useful and complex substrates are main 
motivations in synthetic chemistry.  In an effort to build large libraries of small molecule of 2,3-
disubstituted benzo[b]thiophenes, 2.37, Larock, et al., 
conducted simple electrophilic heterocyclization of 2-
alkynl-thioanisole, 2.36, starting materials.42  These aryl 
methyl sulfides, 2.36, were previously made in good 
yields via Sonogashira coupling of 2-iodo-thioanisole.  
With a large library of 2-alkynl-thioanisoles, the 
preparation of benzo[b]thiophenes with further synthetic utility commenced.  The use of 
halogens as electrophilic species is well known.  To this end Larock chose I2 to induce 
electrophilic cyclization of the 2-iodo-thioanisole, 2.36, which would produce 2-aryl-3-iodo-
benzo[b]thiophenes, 2.37, readily able to undergo further planned palladium catalyzed 
coupling.42  Using a slight excess of I2 in DCM at room temperature, the 2-alkynyl-thioanisole, 
2.36, derivatives readily cyclized to the 2-aryl-3-iodo-benzo[b]thiophenes, 2.37, in excellent 
yields, 71%-96%.42 
Heterocycle annulation is known to be accomplished through cation formation from 
proton-induced dehydration.  This strategy was employed when designing 2,3-diaryl-
benzo[b]thiophene, 2.39, as a possible 
anti-tubulin agent by Pinney et al.4  The 
straightforward strategy involved first 
nucleophilic attack of aryl thiols on -
bromo-acetophenone, leading to 2-
arylthio-acetophenones, 2.38.4  Heterocyclic annulation to 2-aryl-benzo[b]thiophenes was 
Figure 40 Electrophilic alkynyl 
activation of 2-alkynyl thioanisoles to 
substituted benzo[b]thiophenes 
Figure 41 Bronsted-Lowery acid promoted heterocyclization 
of 2-arylthio-acetophenones to substituted benzo[b]thiophenes 
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accomplished by heating the 2-arylthio-acetophenones, 2.38, with polyphosphoric acid.  Of 
significant note is the formation of C(2) substituted benzo[b]thiophenes, 2.39, via a C(3)-C(2) 
aryl shift.4  Further substation at the C(3) was carried out by conventional Friedal-Craft acylation 
protocols. 
Although straightforward and convenient, the proton mediated heterocyclization of 2-
arylthio-acetophenones induced an aryl shift rendering a 2-aryl-benzo[b]thiophene.  In an effort 
to maintain the starting 2-arylthio-acetophenones, 2.40, without inducing the C(3)-C(2) aryl shift 
during the annulation process, Kim 
et al., set forth to developed mild 
conditions to prompt 
heteroannulation to yield 3-aryl-
benzo[b]thiophenes, 2.41.43  It was 
found the use boron trifluoride-diethyletherate at room temperature induced 2-arylthio-
acetophenones, 2.40, to cyclize to the desired 3-aryl-benzo[b]thiophenes, 2.41, in only 10%-15% 
after a day.  To maintain these mild reaction conditions yet increase the efficiency of product 
formation, the authors used boron trifluoride-diethyletherate as a solvent.43  This protocol 
increased the 3-aryl-benzo[b]thiophenes, 2.41, yield to 81%-95%.43  Both electron-withdrawing 
and electron-donating aryl derivatives were compatible with the use of boron trifluoride-
diethyletherate to induce cyclization. 
 
Figure 42 Boron trifluoride-diethyletherate promoted 
heterocyclization of 2-arylthio-acetophenones to substituted 
benzo[b]thiophenes 
2.2 BENZO[B]FURAN SYNTHETIC CONSTRUCTION METHODS 
Palladium based cross coupling in the formation of heterocyclic systems is well studied.  
The wide commercial availability of halo-substituted aryl compounds allows simple construction 
of complex heterocyclic systems in few synthetic steps.  
The coupling via Pd catalysis of an alkene to halo-alkyl 
or halo-aryl functionalities is known as the Heck 
reaction.  This approach has been used in construction 
of benzo[b]furans.  Larock et al., successfully 
employed an intramolecular Heck cross coupling reaction to produce benzo[b]furans.  Starting 
from 2-iodo-phenol allylethers, 2.42, the use of Pd(OAc)2 catalyst in DMF at 80 °C formed the 
desired 3-substituted-benzo[b]furan, 2.43, in moderate to good yields, 40%- 83%.44  The authors 
noted the importance of sodium formate which was 
speculated to reduce the formation of -allyl palladium 
species within the reaction media.  Using similar 
reaction conditions as Larock, Kozikowski et al., 
demonstrated the intramolecular Heck reaction of a 
Figure 43 Pd catalyzed Heck reaction 
toward the synthesis of substituted 
benzo[b]furans 
Figure 44 Pd catalyzed Heck reaction for 
highly complex 2-bromo-phenol allylether, 2.44, to benzo[b]furan indolactam analogues 
synthesize benzo[b]furan intermediate 2.45 in good yields, 79%-83%, to fabricate indolactam 
analogues.45 
The Sonogashira reaction has been used in constructing benzo[b]furans by Kundu et al.46 
Using commercially available terminal alkynes, 2.47, and 2-iodo-phenol, 2.46, the authors 
developed methodology to perform a tandem aryl-alkyne coupling followed by nucleophilic 
heteroatom attack of an activated alkyne and heterocycle formation, forming 2-substituted-
33 
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benzo[b]furans, 2.48.  Screening of reaction conditions found PdCl2(PPh3)2 and CuI the most 
effective catalyst combination.46  The reaction 
conditions were compatible with a wide variety 
of aryl, alkenyl and alcohol functionalized 
terminal alkynes, producing 2-substituted-
benzo[b]furans in moderate to good yields, 61%-88%. 
In a continuation of exploiting the reactivity of alkynes in heterocycle annulation, Larock 
et al., developed conditions for the formation of 2,3-disubstituted benzo[b]furans from simple 2-
iodo-phenols, 2.46, and internal alkynes, 2.49.47  Using five molar percent of Pd(OAc)2 at 
elevated temperatures and under basic conditions, the heteroannulation of 2-iodo-phenol, 2.46, 
was readily accomplished.  Sterically bulky 4,4-dimethylpent-2-yne produced the benzo[b]furan, 
2.50, in good yield of 86%, however, triisopropyl(prop-1-yn-1-yl)silane produced a synthetically 
useful 2-silyl-3-methyl-benzo[b]furan, 2.50, in excellent 90%.47  The electron withdrawing ethyl 
3-phenylpropiolate produced a mixture of 
substitution isomers, 2.50, in 70%.  In a 
purposed mechanistic pathway the catalyst first 
undergoes oxidative insertion of the iodo-aryl 
bond.  The Pd center then complexes with the 
alkyne and followed by a 1,3-insertion, leading to a Pd-alkenyl intermediate.47  The Pd then 
complexes to the oxygen and the catalyst undergoes a reductive elimination, yielding the original 
catalyst and the 2,3-disubstituted benzo[b]furan.  This methodology represents a straightforward 
means to the highly substituted benzo[b]furan from simple and commercially available starting 
Figure 45 Sonogishira coupling and tandem 
heteroannulation for the synthesis of substituted 
benzo[b]furan 
Figure 46 Pd catalyzed heteroannulation of 2-iodo 
phenol and internal alkynes for benzo[b]furan synthesis 
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materials and shows tolerance to sterically large starting alkynes, with the drawback of the need 
for elevated temperatures which may effect thermally unstable functionalities. 
Yang et al., developed useful methodology for multi-substituted benzo[b]furans via 
palladium catalysis under a carbon monoxide atmosphere from simple 2-alkynyl-phenols.48   The 
strategy centered around the aryl carbonylation at the C(3) position after heterocycle annulation.  
The commercial availability of the 2-alkynyl phenol, 2.51, starting materials and aryl iodide, 
2.52, coupling partner offers an economic and straight forward means to produce highly 
substituted benzo[b]furan 
products, 2.53.  The initial 
screenings of reaction 
conditions with 2-
(phenylethynyl)phenol and 
Pd(Ph3P)4 surprisingly produced 2-alkynyl phenolic esters and only trace amounts of the desired 
product.48  To alleviate the unwanted product formation, an increase of Lewis acid character of 
the Pd catalyst was thought to better activate the alkyne, thus inducing nucleophilic attack and 
annulation.  The addition of silver salts to the reaction was found to reverse the above reaction 
impasse, producing the 3-carbonyl-2-aryl benzo[b]furan in 30% and the unwanted 2-alkynyl 
phenolic ester in trace amounts.  The substrate scope was evaluated next, using a highly 
substituted, methyl (E)-3-(4-hydroxy-3-methoxy-5-(phenylethynyl)phenyl)acrylate, 2.51.  Using 
a five molar percent Pd(Ph3P)4, an atmosphere of carbon monoxide, and 4-methoxy phenyl 
iodide, 2.52, at 50 °C successfully produced the benzo[b]furan product, 2.53, in good yield of 
86%.48  Moving to screen the effects of other aryl iodides, 2.52, phenyl iodide and thiophene-2-
iodide again produced the substituted benzo[b]furans, 2.53, in good yields, 91% and 68%.  The 
Figure 47 Pd catalyzed carbonylative heteroannulation to substituted 
benzo[b]furans 
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use of electron withdrawing 4-trifluoromethyl phenyl iodide and 4-acyl phenyl iodide produced 
the benzo[b]furan products, 2.53, in moderate yields of 45% and 61%.  This methodology shows 
high tolerance to highly substituted starting material variations and readily produces 3-carbonyl-
2-aryl benzo[b]furans in good yields.48 
The use of phenols as an economic and abundant starting material is a desirable means to 
produce the benzo[b]furan core by palladium catalyzed heteroannulation.  Maiti et al., developed 
a highly versatile method of heteroannulation by palladium catalyzed C-O/C-C bond formation 
between phenol, 2.54, and alkenyl, 2.55, starting materials producing C(2) substituted 
benzo[b]furans, 2.56.49  The authors found ten molar percent of Pd(OAc)2 catalyst, 1,10-
phenanthroline as ligand, Cu(OAc)2 as oxidizing agent, and NaOAc as base in 1,2-dichloroethane 
at 110 °C the optimal conditions to transform the 4-nitro phenol, 2.54, and styrene, 2.55, to 
corresponding 5-nitro-2-phenylbenzofuran, 2.56, in excellent 94% yield.49  The substrate scope of 
the reaction was impressive.49  The use 
of 4-nitro-phenol, 2.54, led to good 
conversion to the 5,2-substitiuted-
benzo[b]furans, 2.56, when either 
electron withdrawing or electron 
donating aryl styrenes, 2.55, were employed as starting materials.  The use of electron 
withdrawing 4-halo-phenol and 4-carbonyl-phenol with aryl styrenes produced the desired 2,5-
substitiuted benzo[b]furans, 2.56, albeit in moderate yields.  Multisubstituted 2,5-dichloro-
phenol and 3,5-dimethyl-phenol, 2.54, were also able to convert to multisubstituted 
benzo[b]furans, 2.56, in moderate yields.  Use of 2-methyl-phenol and 2-phenyl-phenol under 
standard conditions also produced 6,2-substitiuted benzo[b]furans, 2.56, in moderate yields 
Figure 48 Pd catalyzed synthesis of benzo[b]furans from phenols 
and styrenes 
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despite of the steric bulk of the starting materials.  The standard reaction conditions also proved 
compatible with the use of aliphatic alkenes.49  The heteroannulation was readily accomplished 
however the occurrence of a variety of substitutions was observed.  The use of terminal alkenes 
provided 2-alkyl benzo[b]furans as well as 3-methyl-2-alkyl benzo[b]furans via allylic 
complexation of the alkene and palladium catalyst.  The standard palladium conditions with 
phenols and aliphatic alkenes provided moderate yields of the benzo[b]furan products with 
complications of isomeric products.49 
In a novel approach to 2,3-substituted benzo[b]furans Gabriele et al. developed a 
palladium catalyzed hetero-cyclization followed by acid-catalyzed dehydration and 
aromatization.50  Starting from simple 2-carbonyl-phenols, the authors installed an alkynyl moiety 
creating 2-(1-hydroxyprop-2-yn-1-yl)phenols, 2.57.  The 2-(2-hydroxybut-3-yn-2-yl)phenol was 
selected as a model substrate and then screened with catalytic amounts of transition metal salts to 
induce heteroannulation to 3-methyl-2-methylene-2,3-dihydrobenzo[b]furan-3-ol, 2.58.  Using 
one molar percent PdI2, two equivalents of KI, and an equimolar amount of morpholine in 
methanol at 40 °C 
efficiently caused the 5-exo-
dig cyclization to the desired 
dihyrdobenzo[b]furan 
product, 2.58, in 98%.50  It 
was also discovered that using one molar percent PdCl2 under the same conditions accomplished 
the desired heteroannulation with only ten molar percent of morphiline to yield 
dihyrdobenzo[b]furan product in 86%.  The substrate scope of the cyclization step was assessed 
with functionalization at the benzylic carbon and substitution of the benzene ring.  Under the 
Figure 49 Pd catalyzed heteroannulation and acid catalyzed aromatization of 
via allylic isomerization 
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PdI2 conditions, both hydrogen and phenyl substitutions of the benzylic carbon, 2.57, were 
tolerated in the cyclization reaction.  The addition of electron withdrawing chlorine at C(4) of the 
benzene ring, as well as electron donating methoxy at the C(4) and C(6) carbons all produced the 
dihyrdobenzo[b]furan product in good yields, 2.58, 82%-88%.  With suitable conditions to 
implement the 5-exo-dig cyclization in good yields, the authors set out to induce aromatization of 
the furan via dehydration of the alcohol moiety.  Envisioned was an acid catalyzed dehydration 
and allylic isomerization via a nucleophilic attack of water.50  The mild heating of 3-methyl-2-
methylene-2,3-dihydrobenzo[b]furan-3-ol, 2.58, in 0.2 M H2SO4 in dimethoxyethane 
successfully produced dehydrative-aromatization reaction, yielding the desired 2-
hydroxymethyl-3-methyl-benzo[b]furan, 2.59, in 83% yield.  The use of methanol as a 
nucleophile was also assessed; using the same conditions as above with 3-methyl-2-methylene-
2,3-dihydrobenzo[b]furan-3-ol and producing 2-(methoxymethyl)-3-methylbenzo[b]furan, 2.59, 
in slightly lower 78%.50  The use of the substituted derivatives described above in the PdI2 
annulation conditions under both acid catalyzed aromatizing conditions led to good yields of the 
2-methyl-benzo[b]furan, 2.59, products; under aqueous solvent 81%-90% and under alcohol 
solvent 70%-90%.50  The lone exception to this trend was the use of 5-chloro-2-methylene-2,3-
dihydrobenzofuran, which only produced the aromatized benzo[b]furan in 65% with the use of a 
water nucleophile and a poor yield of 15% when methanol was used as a nucleophile, the yield 
was increased to 65% with heating of the reaction medium.50 
Kim, et al. studied the use of quinols in a platinum catalyzed rearrangement and 
cyclization to the formation of 2-substituted-5-hydroxybenzo[b]furans.51  The authors envisioned 
that the starting quinol substrate would rearrange to a phenol derivative which then would 
proceed through a 5-endo-dig cyclization producing the heterocyclic 2-substituted-5-
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hydroxybenzo[b]furan.51  In a single step, the starting quinol, 2.60, was made via nucleophilic 
addition of lithium acetylides on 1,4-benzoquinone.  The screening of optimal reaction 
conditions and catalysts found that quinol 2.60 underwent the alkynyl rearrangement and 
cyclization with ten molar percent of PtCl2 with a 20:1 DME:methanol solvent at 40 °C, yielding 
2-phenyl-5-hydroxybenzo[b]furan, 2.61, in 
86%.51  The use of PtCl4 in only five molar 
percent in DME at room temperature gave a 
comparable yield of 78%.  With reaction 
conditions understood, the breadth of substrate 
scope was assessed by variation of the terminus of the alkyne sub-moiety.  Aryl, 2.60, C(4) 
substitution of methoxy and methyl as well as C(3)/C(5) dimethoxy both produced the 
corresponding 2-aryl-5-hydroxybenzo[b]furans, 2.61, in good yields 75%-81%.  Reactions with 
electron withdrawing 4-fluoro, and 3-fluoro aryl moieties using PtCl4 proceeded in 81% and 
83%.  The alkynyl thiophene-3-yl was able to produce the 2-thiophene-3-hydroxybenzo[b]furan 
in 86%.  Moving to alkyl alkyne substitutions, phenylethyl, t-butyl, n-butyl, cyclohexenyl, and 
cyclopentyl all showed competency toward cyclization via PtCl2 catalysis, producing 2-alkyl-5-
hydroxybenzo[b]furans, 2.61, in 69%-79%.51  The facile method of starting material construction 
and substrate compatibility of the reaction conditions offers a broad prospect of utility in the 
formation of 2-substituted-5-hydroxybenzo[b]furans, 2.61, via the platinum catalyzed quinol, 
2.60, rearrangement and intramolecular heterocyclization. 
Nakamura et al., focused on the electrophilic Zn
II 
activation of ortho-phenol-ynes, 2.62, 
as a means of benzo[b]furan construction.52  Previously, diethylzinc reagents were used to achieve 
furan cyclization; however, the reaction was sluggish, and it was perceived that a stronger 
Figure 50 Pt catalyzed tandem quinol rearrangement 
and heteroannulation for substituted benzo[b]furan 
synthesis 
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Lewis acid could activate the substrate more readily.  2-(Phenylethynyl)phenol, 2.62, as a model 
substrate was first deprotonated with an equivalent of n-BuLi followed by the addition of ZnCl2. 
The zinc intermediate, 2.63, was then refluxed in toluene to induce the cyclization forming the 2-
phenyl-benzo[b]furan product, 2.64, in quantitative yield.52  The reaction conditions tolerated 
variation of alkynyl terminus, 2.62, and aryl, alkyl, heterocyclic, and benzylic functionalities 
produced excellent yields of 
86%-100%.  Of note, when 
R=H, no desired benzo[b]furan 
was produced.  Nakamura 
further elaborated the utility of this 
chemistry by demonstrating that the organo-zinc intermediate, 2.63, could be used for further 
bond formation.  The addition of CuCN·2LiCl in the presence of zinc intermediate 2.63 induced 
trans-metalation and, in the presence of an electrophile, allowed nucleophilic attack of the copper 
species to yield 2,3-disubstituted benzo[b]furans, 2.64.52  The use of allyl bromide, cinnamyl 
bromide and benzoyl chloride as electrophiles produced 2-phenyl-3-substituted benzo[b]furans 
in 97%, 98% and 91%.  Benzaldehyde as an electrophile produced the 2-phenyl-3-benzol 
benzo[b]furan, 2.64, in good yield of 68%.  Michael electrophiles 2-cyclohexen-1-one and 
diethyl 2-ethylidenemalonate successfully underwent the 1,4-addition producing the 2-phenyl-3-
alkyl-benzo[b]furan, 2.64, again, in good yields of 77% and 95%.52  The ZnCl2 mediated 
cyclization represents a useful method to form 2-substituted benzo[b]furans or further 
substitution via copper-3-benzo[b]furan nucleophiles producing 2,3-substituted benzo[b]furans.  
A drawback of this method is the need for equimolar amounts of the metallic reagents required 
for annulation chemistry.          
Figure 51 Zn induced heteroannulation of 2-alkynyl phenols 
to substituted benzo[b]furans 
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Although the use of transition metals in benzo[b]furans formation from simple starting 
materials is well documented, the drive to use more inexpensive catalysts remains.  To this end 
Venkaturaman et al., have developed a high yielding copper catalyzed Sonogishira-type coupling 
of aryl acetylenes, 2.66, and 2-
iodo-phenols, 2.65, followed by 
heterocycle annulation.53  Using 
iodobenzene and phenyl acetylene 
as a Sonogishira proxy reaction for catalyst efficiency, the authors found [Cu(1,10-
phen)(Ph3P)2]NO3 most effective and proceeded to identify conditions to generate the 
benzo[b]furan.  Using 2-iodo-phenol, 2.65, and phenyl acetylene, 2.66, it was established that ten 
molar percent of [Cu(1,10-phen)(Ph3P)2]NO3 with two equivalents of Cs2CO3 in refluxing 
toluene produced 2-phenyl-benzo[b]furan, 2.67, in an excellent 92%.53  The substrate scope was 
then assessed.  The aryl acetylenes, 2.66, showed tolerance to electron withdrawing and electron 
donating functionalities as well as ortho and para substitutions producing the 2-aryl-
benzo[b]furans, 2.67, in yields 62%-91%.  Of significance was the use of 4-vinyl-phenyl 
acetylene.  No Heck type product was observed, only 2-(4-vinylphenyl)benzo[b]furan in 68%.  
The authors then moved to studying substitutions of the 2-iodo-phenols, 2.68, at the C(4) under 
standard reaction conditions with phenyl acetylene, 2.69.  Without exception, the 2-iodo-phenols 
derivatives, 2.68, were more robust in producing the desired 2,5-disubstituted-benzo[b]furans, 
2.70.53  Substituting the C(4) 2-iodo-phenol with methyl, t-butyl, or phenyl functionalities 
produced the corresponding   2,5-disubstituted-benzo[b]furans, 2.70, in good yields of 79%-85%.  
Figure 52 Cu catalyzed tandem Sonogishira like coupling and 
heteroannulation of 2-iodo phenol and aryl acetylenes toward substituted 
benzo[b]furans 
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When electron withdrawing phenol derivatives (bromo, chloro, and cyano) were placed at the 
C(4), even better yields of the 2,5-disubstituted-benzo[b]furans, 2.70, were seen.53  This reaction 
protocol represents an economic 
means with simple starting 
materials to achieve mono/poly-
substituted benzo[b]furans with 
high tolerance to functionalization of both the alkynyl and phenolic starting materials in 
excellent yields. 
 
 
 
 
 
 
 
 
 
Figure 53 Cu catalyzed tandem Sonogishira like coupling and 
heteroannulation of 2-iodo phenols and phenyl acetylene toward 
substituted benzo[b]furans 
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3.0 MICROWAVE-ASSISTED DEHYDROGENATIVE DEHYDRO-DIELS-ALDER 
REACTION TO BENZOFUSED HETEROCYCLES. 
Building on the successful selective conversion of styrene-alkynyl substrates to the 
cyclic naphthyl annulation products via microwave-assisted intramolecular dehydro-Diels-Alder 
(IMDDA) reaction, work commenced on exploring the aryl -bond component of the diene with 
the hope to eventually produce benzofused heterocycles under the analogously selective solvent 
conditions as described previously.54 
The IMDDA reaction was hypothesized to be a suitable means to form 
benzo[b]thiophene derivatives via benzene ring annulation, an orthogonal strategy to those 
commonly employed when starting from ortho-alkynyl benzenethiols.  Envisioned was a 
thiophene-alkene diene that would undergo the [4+2] reaction in the presence of an activated 
alkynyl dienophile to yield the benzofused annulation product which could then be compared to 
findings of the styrene-yne substrates.54  An ester tether was previously employed with the 
styrene-yne substrates.  Due to the excellent product selectivities as well as the synthetically 
facile means of esterification, the same ester tether was deemed appropriate for preliminary 
thiophene substrates.  Construction of the diene-dienophile substrate began first with alkene 
installation.55
 44 
After surveying the literature it was determined exocyclic olefin installation could be 
accomplished with the use of thiophene-3-carbaldehyde, 3.02, and triethyl phosphonoacetate, 
3.01, under Horner-Wadsworth-Emmons olefination conditions.56  At 0 °C and with NaH as 
base, the reaction was completed in three hours to yield the product, 3.03, in quantitative yield.  
The desired compound was confirmed via 1H NMR with observance of the two resonances that 
appeared as doublets at 7.67 ppm and 6.26 ppm, each integrating to a single proton.  Only the 
trans isomer was observed evidenced by a coupling constant of 15.9 Hz for both doublets.  The 
next step in the diene-dienophile construction was conversion of the thiophene-3-acrylic ethyl 
ester, 3.03, to the allylic alcohol, 3.04.57  The reduction of the ester to the desired alcohol was 
performed with use of three equivalents of diisobutyl aluminum hydride as a hydride source.  A 
solution of thiophene-3-ethyl acrylate, 3.03, was cooled to -78 °C and diisobutyl aluminum 
hydride added, keeping the temperature constant for forty five minutes.  After quenching with 
an aqueous sodium potassium tartrate and purification, the thiophene-3-allylic alcohol, 3.04, 
was collected in 75% yield.  The penultimate synthetic manipulation was completion of the 
diene-dienophile substrate via tethering of an ester functionality.  While there are many means 
to accomplish this transformation it was thought that the potentially reactive nature of the diene 
Figure 54 Synthetic scheme of thiophene(C3) diene-yne precursor and solvent based microwave Diels-Alder 
reaction 
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and alkynyl substrates could complicate the step and, therefore, the mildest means available 
were chosen.  Carbodiimide-mediated esterification showed capable of coupling cinnamyl 
alcohol and various alkynyl acids in previous work.55  To accomplish the esterification of 
thiophene-3-allyl alcohol, 3.04, and 3-phenyl propiolic acid, 3.05, 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide was chosen due to the advantageous purification ease when 
compared to the more commonly utilized N,N'-dicyclohexylcarbodiimide.  Thiophene-3-allyl 
alcohol, 3.04, and 3-phenyl propiolic, 3.05, were dissolved in dichloromethane at room 
temperature and a catalytic amount of dimethylaminopyridine was added.  When the solution 
was homogenous, an excess amount of 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide was 
added in a single portion and the reaction stirred at room temperature overnight.  After 
quenching the reaction, thiophene diene-yne, 3.06, was isolated in 75% yield. 
With the heterocyclic diene-yne substrate, (E)-3-(thiophen-3-yl) allyl 3-
phenylpropiolate, 3.06, in hand the solvent dependent IMDDA reaction of 3.06 was attempted.  
The use of nitrobenzene as solvent was first examined with the goal of forming the tricyclic 
aromatic benzo[b]thiophene lactone.55  (E)-3-(Thiophen-3-yl) allyl 3-phenylpropiolate, 3.06, 
was dissolved in nitrobenzene to a final concentration of 0.06 M and placed in an Anton Paar 
Monowave 300.  The reaction solution was then heated to 225 °C for 3 minutes; during which 
time the solution changed from clear to an amber coloration.  After purification, 1H NMR 
analysis showed a singlet at 5.40 ppm integrating to two protons, belonging to the methylene of 
the lactone sub-moiety.  All other 1H NMR signals were within the aromatic region as expected; 
with the notable singlet from the single aromatic carbocycle at 7.93 ppm.  Additional evidence 
for the product identity was obtained using HRMS (TOF MS ES+), and the m/z ratio found to 
be 266.0422.  The IMDDA proved highly efficient, and the benzo[b]thiophene lactone, 3.07a, 
was isolated in 96% yield. 
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With this promising result, the next iteration focused on elucidating conditions for the 
selective formation of the dihydrobenzo[b]thiophene.  Dimethylformamide was chosen with the 
desire to form the tricyclic dihydrobenzo[b]thiophene lactone product 3.07b.  An Anton-Paar 
Monowave 300 was again used as the microwave source.  (E)-3-(Thiophen-3-yl) allyl 3-
phenylpropiolate, 3.06, was dissolved in anhydrous DMF to a final concentration of 0.06 M.  
The reaction solution was then heated to 225 °C for 3 minutes, during which the solution 
changed from clear to an amber coloration.  After purification and 1H NMR analysis the 
annulation product, 3.07b of the IMDDA reaction proved present.  The product showed a 
substantially different NMR spectrum as compared to the benzo[b]thiophene lactone, 3.07a.  
This was surmised based on five distinct signals in the 1H NMR which are present in related 
dihydronaphthyl products previously identified: (1) two triplets belonging to the methylene 
lactone protons at 4.7 ppm and 4.03 ppm; (2) a multiplet belonging to the methine proton from 
3.66-3.55 ppm; (3) a doublet of doublets at 3.13 ppm and a triplet at 2.66 ppm belonging to the 
methylene protons of the six-membered ring.55  All signals integrate to a single proton, 
consistent with the above assignment.55  This spectral data, along with HRMS (TOF MS ES+) 
mass which was found to be 268.0576 m/z ratio, offer compelling evidence that the IMDDA 
reaction was successful both with regard to utilizing the aromatic heterocycle thiophene, 3.06, 
as a diene component and producing 3.07b in 86% yield as 96:4 ratio of 3.07b:3.07a, as the 
major product based on solvent selection.  However, despite these promising initial results, a 
small amount of the fully aromatic benzo[b]thiophene lactone, 3.07a, was observed.  This side 
product is evidenced spectrally via 1H NMR by a singlet at 5.40 ppm representing the aliphatic 
protons of the lactone moiety 3.07a 
Having established the viability of thiophene diene-yne 3.06 for use in the microwave-
assisted IMDDA reaction and product selection based on solvent choice, the focus then shifted 
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to expand the substrate scope on two fronts: changing the position of the linear sub-segment to 
the C(2) carbon of the thiophene; and replacing the thiophene heterocycle with a furan moiety. 
To construct the isomeric C(2) thiophene diene-yne, (E)-3-(thiophen-2-yl)allyl 3-
phenylpropiolate, 3.11, thiophene-2-carbaldehyde, 3.08, was subjected to the same Horner-
Wadsworth-Emmons olefination conditions which had successfully been employed for 3.02.56  
At 0 °C triethyl phosphonoacetate, 3.01, was deprotonated with NaH, thiophene-2-
carbaldehyde, 3.08, added dropwise, the reaction warmed to room temperature and stirred for 
three hours to yield the thiophen-2-ethyl acrylate, 3.09, in 89% yield.  Reduction to the allylic 
alcohol, 3.10, was accomplished with diisobutyl aluminum hydride at -78 °C followed by 
quenching and vigorous stirring with half saturated aqueous solution of sodium potassium 
tartrate overnight.57  After purification, the alcohol, 3.10, was obtained in 99% yield.  N,N'-
dicyclohexylcarbodiimide mediated esterification with thiophene-2-allyl alcohol, 3.10, and 3-
phenyl propiolic acid, 3.05, with dimethylaminopyridine as activation catalyst successfully led 
to (E)-3-(thiophen-2-yl)allyl 3-phenylpropiolate, 3.11, in 68% yield. 
With the thiophene 3.11 in hand, the product selection in the microwave-assisted 
IMDDA reaction from solvent choice was evaluated.  Performing the IMDDA reaction with 
(E)-3-(thiophen-2-yl)allyl 3-phenylpropiolate, 3.11, in nitrobenzene, 0.06 M, heating with an 
Anton Paar Monowave 300 (225 °C) produced the fully aromatic benzo[b]thiophene lactone, 
3.12a’, in 90% yield.  The observance of a singlet at 5.40 ppm with an integration value of two 
Figure 55 Synthetic scheme of thiophene(C2) diene-yne precursor and microwave Diels-Alder 
reaction 
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as well as a singlet at 7.93 ppm corresponding to the lone aromatic carbocycle proton supported 
the desired product assignment.  This was further corroborated with HRMS (TOF MS ES+). 
Thiophene diene-yne isomers 3.06 and 3.11 proved successful in undergoing the 
microwave-assisted IMDDA reaction.  Performing the IMDDA reaction of 3.06 and 3.11 in 
nitrobenzene yielded the fully aromatic benzo[b]thiophenes 3.07a, 96% yield, and 3.12a’, 90% 
yield, in short reaction times and as the only observed product. 
We next opted to broaden the substrate of the IMDDA.  Having shown that a single 
alkene belonging to the thiophene heterocycle could participate as a portion of the diene, furan 
heterocycle was considered to perhaps exhibit similar reactivity as part of a diene within the 
IMDDA.  Hence, construction began to synthesize a furan diene-yne substrate with an ester 
tether linking diene and dienophile.  The synthetic route employed in the construction of the 
previous thiophene examples was followed, however; when minor reaction differences were 
found within the literature these took precedent when applicable. 
To begin the substrate synthesis, Wittig reaction conditions were employed.  The 
phosphine Wittig reagent was generated by the reaction of triphenyl phosphine with ethyl 2-
bromoacetate in 
toluene at room 
temperature.58  
Almost 
immediately a 
white precipitate 
formed on the 
walls of the 
flask.  The reaction was stirred at room temperature overnight and analysis of the precipitate 
Figure 56 Synthetic scheme of furan(C3) diene-yne precursor and microwave Diels-Alder 
reaction 
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was consistent with literature reports.  The olefination reaction using Wittig conditions was then 
commenced.59  First, deprotonation of the phosphonium bromide salt, 3.13, to the nucleophilic 
ylide, 3.14, was easily accomplished by washing the salt with 2 M sodium hydroxide, and 
extraction with dichloromethane.  Upon solvent removal the beige solid Wittig reagent, 3.14, 
was used in the next step without purification.  The phosphorus ylide, 3.14, was dissolved at 
room temperature in tetrahydrofuran and the solution warmed to reflux.  Once at refluxing 
temperature, furan-3-carbaldehyde, 3.15, was added dropwise into the solution and kept at the 
reflux temperature for two hours after which it was cooled to room temperature.  After 
purification, ethyl (E)-3-(furan-3-yl)acrylate, 3.16, was obtained in 83% yield.  The Z-isomer 
was observed in 1% yield.  Reduction to the allylic alcohol was accomplished with treatment of 
ethyl (E)-3-(furan-3-yl)acrylate, 3.16, with lithium aluminum hydride at room temperature.59  
(E)-3-(Furan-3-yl)prop2-en-1-ol, 3.17, was recovered in quantitative yield and the crude product 
proved very pure with no further purification carried out.  With the allylic alcohol, 3.17, in 
hand, installation of the alkynyl dienophile via ester linkage was required.  The esterification 
was performed with addition of the allylic alcohol, 3.17, 3-phenyl propiolic acid, 3.05, and a 
catalytic amount of dimethylaminopyridine to a round bottom flask followed by solvation with 
dichloromethane.  When the reaction solution was homogenous the esterifying reagent, N,N'-
dicyclohexylcarbodiimide, was added in a single portion; changing the reaction solution from 
clear to dark brown.  The reaction was stirred at room temperature for three hours after which 
the solution was poured directly onto a silica gel plug and the products eluted with diethyl ether.  
After purification, (E)-3-(furan-3-yl)allyl 3-phenylpropiolate, 3.18, was collected as a white 
solid in 67% yield.  The furan diene-yne substrate, (E)-3-(furan-3-yl)allyl 3-phenylpropiolate, 
3.18, was now primed to attempt the IMDDA reaction.  The successful reaction conditions 
employed for annulation of the thiophene diene-yne were thought feasible for the furan 
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substrate.  Motivated by the high rate of success in formation of fully aromatic fused cycles, the 
microwave-assisted IMDDA reaction in neat nitrobenzene furan diene-yne, 3.18, was first 
assessed.  3.18 was added to a microwave vial and nitrobenzene added to the desired 
concentration of 0.06 M.  The reaction solution was heated to 225 °C over 3 minutes and held at 
225 °C for 3 minutes with an Anton Paar Monowave 300.  This produced the fully aromatic 
benzo[b]furan lactone, 3.19a, in a 78% yield.  The observance of a singlet at 5.40 ppm with an 
integration value of two as well as a singlet at 7.93 ppm corresponding to the lone aromatic 
carbocycle proton supported the desired product presence.  The formation of 3.19a was further 
reinforced with HR MS (TOF MS ES+) m/z ratio found 250.0630. 
With the moderate success of benzo[b]furan annulation product, 3.19a, via the 
microwave-assisted IMDDA reaction, the variance of the position of the acyclic framework to 
the C(2) of the furan ring commenced.  The same synthetic approach used in the previous 
example was done starting from furan-2-carbaldehyde, 3.20, to yield ethyl (E)-3-(furan-2-
yl)acrylate, 3.21 in 83% yield.59  The transformation to the allylic alcohol was accomplished 
using lithium aluminum hydride as reductant, having the reaction completed in 1.5 h at room 
temperature.  Analysis of the crude material showed conversion to (E)-3-(furan-2-yl)prop-2-
en1-ol, 3.22.  However, a significant amount of over reduction occurred reducing both the ester 
moiety 
as well 
as the 
acyclic 
alkene to 
the fully saturated alcohol.  In subsequent reductions, diisobutyl aluminum hydride was used as 
reductant alleviating the reduction of the acyclic olefin, recovering 3.22 in 81%.  Purification 
Figure 57 Synthetic scheme of furan(C2) diene-yne precursor and microwave Diels-Alder reaction 
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issues were encountered when performing previous esterification reactions with N,N'-
dicyclohexylcarbodiimide, therefore, to obtain (E)-3-(furan-2-yl)allyl 3-phenylpropiolate, 3.23, 
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide was supplemented for use.  After charging a 
round bottom flask with 3.22 and 3.05 and dissolving the contents with dichloromethane, 1-
ethyl-3-(3-dimethylaminopropyl)carbodiimide was added in a single portion and the reaction 
stirred for 20 hours at room temperature.  Upon purification, 3.23 was obtained in 80% yield as 
a clear oil. 
Performing the IMDDA reaction with (E)-3-(furan-2-yl)allyl 3-phenylpropiolate, 3.23, 
in nitrobenzene, 0.06 M, with an Anton Paar Monowave 300 via ramping to 225 °C in 3 
minutes and heating at 225 °C for 3 minutes produced the fully aromatic benzo[b]furan lactone, 
3.24a’, in 65% yield.  The observance of a singlet at 5.38 ppm with an integration value of two 
as well as a singlet at 7.73 ppm corresponding to the lone aromatic carbocycle proton supported 
the presence of the desired product.  This was further corroborated with HRMS (TOF MS ES+) 
m/z ratio found to be 250.0607. 
The promising results of both the thiophene and furan substrates prompted further 
examination of solvent as to assess the role in the selective formation of the dihydro-annulation 
products versus the fully aromatic cycles in the microwave-assisted IMDDA reaction.  
Thiophene-3 substrate, 3.06, was selected due to the higher degree of success in terms of yields 
from the previous experiments.  Beginning, ortho-dichlorobenzene was selected, in part to the 
high boiling point as well as complete selectivity in formation of the naphthalene product with a 
full carbon tether.54  The IMDDA reaction was performed with 3.06 varying both the 
temperature and the time of the reaction.  All experiments gave mixtures of 3.07a:3.07b, entries 
1-5, Table 1.  Some trends did emerge; lowering the temperature from 225 °C to 180 °C 
resulted in a lower ratio of 3.07a:3.07b.  Lowering the reaction temperature further to 150 °C 
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slowed the formation of product resulting in large amount of unreacted starting material, while 
still producing a similar 1:2 mixture of 3.07a:3.07b.  Upon lowering the reaction temperature to 
120 °C, the reaction time was pushed to one hour in order for the products 3.07a and 3.07b to 
begin to eclipse the unreacted 3.06 as the major components in the experiment while still 
yielding sub-par selectivity.  When changing the reaction solvent to 1,2-dichloroethane, similar 
results were observed when attempting the IMDDA reaction of 3.06 at 120 °C, entry 6 Table 1.  
A strikingly similar ratio was observed when heating 3.06 at 120 °C in 1,2-DCE for 1.5 hours as 
to that of o-DCB for 1 hour; the distribution of 3.07b remained the same while a slightly larger 
amount of 3.07a observed.  The IMDDA reaction took 5 hours to be fully consumed of 3.06, 
entry 7 Table 1, favoring the formation of 3.07a.  Although the use of o-DCB and 1,2-DCE did 
not prove fruitful in allowing product selectivity for the microwave-assisted IMDDA, a desire to 
determine the lowest necessary amount of nitrobenzene while still allowing selective formation 
of the aromatic Diels-Alder products remained.  An amount of 20% nitrobenzene/o-
Table 1 Exploration of solvent role in product determination on 
(E)-3-(thiophen-3-yl)allyl 3-phenylpropiolate 
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dichlorobenzene solution was found suitable for selective formation of the naphthalene 
lactone.55  Thiophene-3, 3.06, was heated at 225 °C for ten minutes in a 20% nitrobenzene/o-
dichlorobenzene solution and proved very promising in delivering the fully aromatic 
benzo[b]thiophene 3.07a with near complete selectivity, entry 8 Table 1.  Lowering 
nitrobenzene to 10% volume and heating at 225 °C for ten minutes led to a small amount of 
starting material remaining.  Extending the reaction time to twenty minutes completed the 
reaction and only slightly reduced the selectivity of product distribution to 3.07a:3.07b, 97:3 
ratio, entries 9 and 10 Table 1.  Further lowering the nitrobenzene to 5% volume solution and 
extending the reaction time to forty minutes produced a ratio of 3.07a:3.07b, 93:7, entry 11 
Table 1, which was thought to be less satisfactory than those previously done.  Therefore, with 
all variables of the reaction conditions in mind, it was determined that a 10% nitrobenzene/o-
dichlorobenzene solvent was the appropriate condition to further study the scope the IMDDA 
reaction.  Thiophene-3, 3.06, was heated at 225 °C in 10% nitrobenzene/o-dichlorobenzene for 
twenty minutes.  Upon removal of solvent and purification with column chromatography, 
IMDDA product was obtained in an 86% yield with the fully aromatic benzo[b]thiophene the 
major compound as a 96:4 ratio of 3.07a:3.07b, entry 1 Table 2. 
Having established optimized conditions for the achievement of fully aromatic 
annulation product as well as a lower overall volume of nitrobenzene, efforts were then set forth 
to expand the substrate scope in two differing respects: (1) replacing the R- group on the 
terminus of the alkynyl dienophile and (2) alteration of heteroatom within the linker segment of 
the substrate.  Having achieved good results with ester 3.06 to benzo[b]thiophene 3.07a via W 
heating at 225 °C for twenty minutes using a 10% nitrobenzene/o-dichlorobenzene (v/v) 
solution the construction of a trimethylsilane alkynyl terminus as well as an aliphatic alkynyl 
terminus commenced.   
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Using thiophene-3-allylic alcohol 3.04 and 3.25 under EDCI esterification conditions at 
ambient 
temperature 
did not yield 
any visible 
ester 
formation.  
To 
accomplish 
the esterification the entire flask contents were solvated in dichloromethane at room temperature 
then lowered to -78 °C.  Once the solution was sufficiently cooled the septa was removed and 
EDCI added in a single portion.  The reaction solution was allowed to warm to 0 °C at which 
point the reaction was quenched.  After purification the desired ester 3.26 was obtained in 70% 
yield.  This synthetic procedure was repeated to produce C(2) analogs.  The use of 3.10 and 3.25 
produced 3.28 in moderate yield of 40%.  The furan-2-allylic alcohol, 3.22, proved less 
successful, producing 3.30 in only 11%.  3.30 proved highly unstable and decomposed rapidly 
at room temperature even upon immediate purification.  The aliphatic ester 3.34 was obtained in 
three steps, starting from alkyne 3.32.  3.32 was deprotonated with n-butyl lithium and carbon 
dioxide added, readily forming the alkynyl carboxylate.66  Quenching with 1 M HCl produced 
3.33 as a white solid.  Esterification was achieved again with 3.04 and 3.33 using EDCI under 
ambient temperature.  After purification the desired ester 3.34 was obtained in 55% yield over 
the two steps. 
Figure 58 Synthetic scheme toward functional variation of ester tether diene-yne Diels-Alder 
substrates 
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The installation of an amide tether linking the heterocyclic diene to the dienophile 
proved more exacting in terms of synthetic utility.  Due to the facile approach to 3.04, it was 
thought that the alcohol could be directly converted to the corresponding amine under 
Mitsunobu reaction conditions.  However, after attempting the reaction and scrutinizing the 
products there was a peculiar new set of signals appeared in the 1H NMR.  The new set of 
signals appeared to show terminal vinyl functionality.  What is proposed to have occurred rather 
than substitution at 
the carbinol carbon 
was in fact a Sn2’ 
and rearrangement of 
the olefin.  From this 
a more classic 
approach to nitrogen 
installation was attempted in the form of the Gabriel anime synthesis.60  To ready 3.04 for direct 
nucleophilic attack, the allylic alcohol was first converted to the corresponding allylic bromide 
with phosphorus tribromide at 0 °C.60  The bromination was monitored via TLC and proceeded 
without incident, however, the allylic bromide was not further purified after quenching rather 
proceeding with the crude product due to potential stability issues.  Moving to nitrogen 
installation the crude thiophene-3-allylic bromide was solvated in anhydrous DMF and in a 
single portion potassium phthalimide added.60  The reaction was stirred at room temperature for 
twenty four hours.  The allylic phthalimide, 3.36, was then purified and obtained in 83% yield 
over the two steps.  Freeing the nitrogen was accomplished by refluxing 3.36 in ethanol with 
hydrazine for three hours.60  The phthalazide by-product began to precipitate out of the refluxing 
solution after an hour and proved difficult to separate from the allylic amine 3.37.  It was found 
Figure 59 Synthetic scheme toward functional variation of amide tether diene-yne 
Diels-Alder substrates 
 56 
that after solvating the reaction solution in a 1:1 water:methanol solution followed by multiple 
extractions with dichloromethane crude 3.37 could be obtained with very little phthalazide 
present.  The last synthetic step prior to the IMDDA was linking the heterocyclic diene and the 
dienophile via amide functionality.  The preferred approach of amidation was conversion the 
alkynyl carboxylic acid first to the acid chloride followed by the addition of 3.37.61  Conversion 
to the acid chloride was achieved by addition of 3.05 and oxalyl chloride with a catalytic 
amount of dimethylformamide at zero degrees.  This was then followed by dropwise addition of 
3.37 to the solution which caused the solution color to change from clear to yellow.  After 
quenching and purification the desired amide, 3.38, was obtained in a poor 25%.  The same 
synthetic approach was taken with regard to the carboxylic acid 3.25 to obtain amide 3.40 in a 
32% yield. 
With the dienophile portion installed, the esters were ready for assessment in the 
microwave-assisted intramolecular Diels-Alder reaction.  The substrates were solvated with 
10% nitrobenzene/o-dichlorobenzene (v/v) solution to a 0.06 M concentration and heated at 225 
°C.  The reaction was monitored via TLC until completion, 20-80 minutes.  All substrates 
underwent the intramolecular Diels-Alder reaction forming the fully aromatic 
benzo[b]thiophene lactone derivatives as major products in good yields.  These exact reaction 
conditions and results are summarized in entries 1-5 Table 2. 
Amides 3.39 and 3.40 were also examined in the microwave-assisted intramolecular 
Diels-Alder reaction.  The amides were solvated with 10% nitrobenzene/o-dichlorobenzene 
(v/v) solution to a 0.06 M concentration and heated at 225 °C.  The reactions were monitored 
via TLC until completion, 30 minutes.  Both substrates underwent the intramolecular Diels-
Alder reaction forming the fully aromatic benzo[b]thiophene lactam derivatives as major 
products in good yields.  These exact reaction conditions and results are summarized in entries 6 
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and 7 Table 2.  The microwave-assisted intramolecular dehydro-Diels-Alder reaction showed a 
high tolerance toward functional variation of the alkynyl terminus and heteroatom linker, albeit 
with varying time components associated with specific substrates.  Both esters and amides 
offered compatible functional linkers to the heterocyclic diene-dienophile subcomponents.  
These ester/amide analogs also showed strikingly similar yields when the equivalent R- group 
functionalities present.  One may conclude that the more demanding structural variable for the 
microwave-assisted IMDDA reaction is the functional group present on the alkyne terminus 
rather than the chosen heteroatom linker. 
In continuation of studies focusing on conditions to allow for the selective formation of 
the dihydrobenzo[b]thiophene IMDDA products, attention was again focused on the use of 
DMF as a solvent.  Having already demonstrated that the microwave-assisted IMDDA reaction 
will produce the dihydrobenzo[b]thiophene 3.07b, entry 1 Table 3, as the major product in 
good yields from diene-yne 3.06, the next step was varying the structural scope of the 
heterocyclic diene-dienophile.  To start, (E)-3-(thiophen-2-yl)allyl 3-phenylpropiolate, 3.11, 
was solvated in DMF to a final concentration of 0.06 M and heated to 225 °C.  Upon removal of 
solvent and purification of the residue, it was determined by column chromatography that (E)-3-
(thiophen-2-yl)allyl 3-phenylpropiolate, 3.11, successfully underwent the IMDDA reaction 
Table 2 Summary of results in opt. aromatic annulation conditions 
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forming the dihydrobenzo[b]thiophene lactone, 3.12b’, in a 58% yield, entry 2 Table 3.  The 1H 
NMR confirmed the formation of dihydrobenzo[b]thiophene lactone, 3.12b’.  Observed were 
two triplets belonging to the methylene lactone protons at 4.70 ppm and 4.03 ppm, a multiplet 
signal belonging to the methine proton from 3.70-3.60 ppm, and a doublet of doublets at 3.20 
ppm and a triplet at 2.80 ppm belonging to the methylene protons of the six membered ring.  
Similarly, this reaction produced a mixture of dihydrobenzo[b]thiophene lactone, 3.12b’, and 
benzo[b]thiophene lactone, 3.12a’, in an improved 97:3 (3.12b’:3.12a’) ratio. 
To assess the utility of (E)-3-(furan-3-yl)allyl 3-phenylpropiolate, 3.18, to form the 
dihydrobenzo[b]furan product, dimethylformamide was again selected as solvent.  3.18 was 
dissolved to a final concentration of 0.06 M with dimethylformamide and heated; ramping to 
225 °C in 3 minutes then holding at 225 °C for 3 minutes with an Anton Paar Monowave 300.  
Upon removal of solvent and purification of the reaction material it was determined that 3.18 
successfully underwent the IMDDA reaction forming the dihydrobenzo[b]thiophene lactone 
3.19b in the low isolated yield of 36%, entry 3 Table 3.  The structure of 3.19b was confirmed 
to be the dihydrobenzo[b]furan lactone based on the distinguishable signature of the aliphatic 
protons as seen in previous reactions which produced similar dihydro-Diels-Alder adducts; two 
diasteriomeric methylene protons of the lactone segment displayed as triplets at 4.70 ppm and 
4.04 ppm, and a methine proton multiplet appeared at 3.72-3.60 ppm.  The remaining protons of 
the six-membered ring showed as doublet of doublets at 2.96 ppm followed by a triplet at 2.63 
ppm.  All signals integrated to a single proton.  Although the outcome of formation of the 
dihydrobenzo[b]furan lactone 3.19b was poor, the results are further complicated by a high 
degree of formation of the fully aromatic benzo[b]furan lactone 3.19a, which after removal of 
solvent was determined to be in a ratio of 88:12 (3.19b:3.19a) in the low yield of 36%.  The 
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formation of 3.19b was further reinforced with HR MS (TOF MS ES+) m/z ratio found 
253.0888 
(E)-3-(Furan-2-yl)allyl 3-phenylpropiolate, 3.23, was now ready to undergo the 
microwave-assisted IMDDA reaction.  To assess the viability of the IMDDA reaction with 3.23 
to afford dihydrobenzo[b]furan lactone, 3.24b’, dimethylformamide was chosen as solvent.  
3.23, was added to a microwave vial and solvated with dimethylformamide to a final 
concentration of 0.06 M.  The reaction solution was heated at 225 °C for 3 minutes with an 
Anton Paar Monowave 300, ramp time 3 minutes.  The IMDDA reaction proved successful with 
3.23 as substrate to afford the dihydrobenzo[b]furan lactone 3.24b’ in a 41% yield, entry 4 
Table 3.  Like with previous dimethylformamide iterations the presence of the fully aromatic 
3.24a’ was observed favoring dihydrobenzo[b]furan lactone; product in a 95:5 ratio of 
(3.24b’:3.24a’).  The 1H NMR exhibited the previously observed pattern of aliphatic protons 
indicating the dihydro-product, this was further reinforced with HR MS (TOF MS ES+) finding 
and m/z of 253.0892. 
Diene-yne 3.34 was solvated in DMF to a final concentration of 0.06M.  The solution 
was then heated at 225 °C for 3 minutes.  Monitoring the reaction via TLC showed that a large 
amount of 3.34 remained, as a result the reaction was heated further, 15 minutes total, until all 
starting material was consumed.  After purification, 1H NMR showed that indeed the reaction 
conditions successfully produced the dihydrobenzo[b]thiophene product indicated by the 
familiar signal pattern encountered with previous dihydro-annulation products.  The observed 
1H NMR signals were as follows: a one-H triplet at 4.63 ppm and a one-H triplet at 3.96 ppm 
(corresponding to the lactone protons) and a one-H multiplet at 3.39-3.29 ppm belonging to the 
tertiary carbon of the fused ring system.  A two-hydrogen multiplet ranging from 3.09-3.01 ppm 
was observed and can be rationalized as the overlap of the axial hydrogen on the methylene 
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carbon of the newly formed ring and a hydrogen belonging to the acyclic methylene carbon of 
the aliphatic R- group.  The next signal was a previously unobserved one hydrogen multiplet at 
2.79-2.73 ppm; this signal belongs to the remaining hydrogen from the acyclic methylene 
carbon of the aliphatic R- group.  A one hydrogen triplet was observed at 2.50 ppm and is part 
of the methylene carbon on the new six membered ring.  The final signals belonging to the 
cyclohexyl protons of the aliphatic R- group, the first observed was a six hydrogen multiplet at 
1.71-1.62 ppm and the second a five hydrogen multiplet at 1.28-1.14 ppm.  The 
dihydrobenzo[b]thiophene product 3.35b was isolated in a good yield of 71%, entry 5 Table 3, 
in a ratio of 93:7 (3.35b:3.35a). 
Moving from the aliphatic R- group on the alkynyl terminus to the trimethyl silane of 
3.26 preliminary reaction conditions were assessed to afford the silylated 
dihydrobenzo[b]thiophene annulation product.  Following previously administered reaction 
parameters, 3.26 was solvated in DMF to a final concentration of 0.06 M.  The reaction solution 
was then heated at 225 °C and the progress of the reaction monitored via TLC.  After three 
minutes of microwave heating, complete consumption of starting materials was shown.  After 
subsequent purification of presumed desired product, scrutiny of the 1H NMR showed 
differently.  The typically observed signals of the dihydroannulation skeleton were observed, 
Table 3 Summary of results with DMF as reaction solvent 
 61 
yet, there was no signal representative of the trimethylsilyl group.  Instead a new signal was 
observed in the aromatic region of the 1H NMR at 7.44 ppm integrating to a single hydrogen.  
The yield for the product was low as well, and only 48% of the desilylated 
dihydrobenzo[b]thiophene product was recovered, entry 6 Table 3.  A substantial amount of the 
fully aromatic desilylated benzo[b]thiophene product was observed though, favoring dihydro 
product in a 88:12 ratio, 3.27b:3.27a.  It was clear that the reaction conditions had caused 
desilylation of the substrate.  A summation of the IMDDA reactions can be seen in Table 3. 
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CONCLUSION 
The above work has provided further applicable scope to the microwave-assisted 
dehydro-Diels-Alder reaction in attainment of several benzofused heterocyclic lactones and 
lactams.  The reactions were completed in short times and in most cases high yields as when 
compared with conventional thermal heating methods.  The major product selectivity of the 
resulting tricycles was based on solvent employed during the reaction.  The reaction tolerated a 
range of terminal substitutions on the alkyne dienophile.  The reaction proved successful when 
the diene-dienophile employed both ester and amide tethers forming the corresponding fused 
lactone/lactam in good yields.  The microwave- assisted intramolecular dehydro-Diels-Alder 
reaction represents a simple means to access highly substituted benzo[b]thiophenes and 
benzo[b]furans. 
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APPENDIX A 
SUPPORTING INFORMATION 
A.1 CHEMICAL CHARACTERIZATION CHECKLIST 
Compound, 
structure, 
or 
table-entry 
number 
 
New Known 
Melting 
point 
range IR 
1H 
NMR 
13C 
NMR 
___ 
NMR MS HRMS 
Copy of 
1H/13C 
NMR 
spectrum 
in SI* 
                        
3.03     x     x x       x 
3.04 
 
  x     x x       x 
3.06 
 
x     x x x     x x 
3.07a 
 
x     x x x     x x 
3.07b   x     x x x     x x 
3.09 
 
  x     x x       x 
3.10 
 
  x     x x       x 
3.11 
 
x     x x x     x x 
3.12a' 
 
x     x x x     x x 
3.12b'   x     x x x     x x 
3.16 
 
  x     x x       x 
3.17 
 
  x     x x       x 
3.18 
 
x     x x x     x x 
3.19a 
 
x     x x x     x x 
3.19b   x     x x x     x x 
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3.21 x x x x 
3.22 x x x x 
3.23 x x x x x x 
3.24a' x x x x x x 
3.24b' x x x x x x 
3.26 x x x x x x 
3.27a x x x x x x 
3.27b x x x x x x 
3.28 x x x x x x 
3.29a' x x x x x x 
3.30 x x x x x x 
3.31a' x x x x x x 
3.34 x x x x x x 
3.35a x x x x x x 
3.35b x x x x x x 
3.36 x x x x x x 
3.37 x x x x x x 
3.38 x x x x x x 
3.39a x x x x x x 
3.40 x x x x x x 
3.41a x x x x x x 
Table 4 Chemical characterization checklist 
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A.2 GENERAL METHODS 
Unless otherwise noted, all reactions were performed in flame-dried glassware sealed 
with rubber septa under a nitrogen atmosphere, and the reaction mixtures were stirred with a 
Teflon-coated magnetic stir bar.  Liquid reagents and solvents were transferred via syringe and 
cannula using standard techniques.  The reaction solvents tetrahydrofuran (THF), 
dichloromethane (DCM), and diethyl ether (Et2O) were dried by passage over a column of 
activated alumina using the Sol-Tek ST-002 solvent purification system; toluene was freshly 
distilled over calcium hydride prior to use.  Chloroform and anhydrous N,N-dimethylformamide 
(DMF) were purchased from Aldrich Chemical Co and used as received.  All other solvents and 
reagents were used as received unless otherwise noted.  Reaction temperatures above 23 °C refer 
to oil bath temperature, which was controlled by an IKAmag temperature modulator.  Reaction 
progress was monitored by thin layer chromatography (TLC) using EMD Chemicals Silica Gel 
60 F254 glass plates (250 μm thickness) and visualized by UV irradiation (at 254 nm) and 
KMnO4 staining.  Purification of the compounds by flash column chromatography (FCC) was 
performed using silica gel (32-63 μm particle size, 60 Å pore size) purchased from Silicycle.  1H 
NMR and 13C NMR spectra were recorded on Bruker Avance 300 MHz, 400 MHz, or 500 MHz 
spectrometers.  1H and 13C chemical shifts (δ) are reported relative to the solvent signal, CHCl3 
(δ = 7.26 for 1H NMR and δ = 77.00 for 13C NMR).  Data are reported as follows: chemical shift 
(multiplicity, coupling constants where applicable, number of hydrogens).  The following 
abbreviations are used to denote multiplicities: s, singlet; d, doublet; t, triplet; q, quartet; p, 
pentet; m, multiplet; b, broad.  Coupling constants, J, are reported in hertz (Hz).  All NMR 
spectra were obtained at room temperature (RT) unless otherwise specified.  IR spectra were 
recorded on a Nicolet Avatar E.S.P.  360 spectrometer and are reported in frequency of 
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absorption (cm-1).  Only selected IR peaks are reported.  High-resolution mass spectral data were 
obtained from the University of Pittsburgh, Department of Chemistry Mass Spectral Facility.  
References located after compound names refer to literature protocols for the preparation of 
these or similar compounds by comparable methodology.  All microwave heating was performed 
using an Anton Paar MonoWave 300 and heating monitored using an internal IR sensor. 
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A.3 COMPOUND SYNTHESIS 
 
Figure 60 Synthetic scheme of thiophene(C3) dien-yne precursor and solvent based microwave Diels-Alder reaction 
 
 
Ethyl (E)-3-(thiophen-2-yl)acrylate (3.03).  In a manner entirely analogous to that previously 
reported,56 a single-necked 250 mL round-bottomed flask equipped with a septum, magnetic 
stirring bar of dimension 150 mm by 100 mm, and nitrogen inlet was flame-dried and allowed to 
cool.  The rubber septum was briefly removed, and the flask was charged with sodium hydride 
(960 mg of a 60% dispersion in mineral oil, 24 mmol) and tetrahydrofuran (80 mL).  The 
mixture was cooled to 0 °C (bath temperature) in an ice bath, and triethyl phosphonoacetate 
(3.01, 4.4 mL, 22.2 mmol) was added drop wise via syringe (approximately 10 min).  After the 
addition was complete, the reaction was stirred at 0 °C for an additional 30 min.  Thiophene-3-
carbaldehyde (3.02, 1.6 mL, 17.8 mmol) was added drop wise via syringe (approximately 10 
min).  During the course of the addition, the solution color became opaque-white.  The reaction 
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temperature was maintained at 0 °C for 15 min, then removed from the ice bath and allowed to 
warm to rt.  The progress of the reaction was monitored by TLC.  After 3 h, the reaction was 
transferred to a separatory funnel, diluted with diethyl ether (60 mL), and washed with deionized 
water (2 x 50 mL).  The organic layer was transferred to an Erlenmeyer flask and dried over 
MgSO4, vacuum filtered, and concentrated under reduced pressure to yield compound 3.03 as an 
amber oil used without further purification (3.2 g, 100%).  Notebook: 01-197, 01-143 
 
Data for 3.0362 
1H NMR (300 MHz, CDCl3)  = 7.67 (d, J = 15.9 Hz, 1 H), 7.49-7.48 (m, 1 H), 7.35-7.28 (m, 2 
H), 6.26 (d, J = 15.9 Hz, 1 H), 4.25 (q, J = 7.2 Hz, 2 H), 1.31 (t, J = 7.2 Hz, 3 H). 
13C NMR (400 MHz, CDCl3)  = 167.2, 138.1, 137.6, 128.0, 127.0, 125.1, 117.9, 60.4, 14.3 
ppm. 
TLC (10% ethyl acetate/hexanes) Rf  = 0.4 
 
 
(E)-3-(Thiophen-3-yl)prop-2-en-1-ol (3.04).  In a manner entirely analogous to that previously 
reported,57 a single-necked 500 mL round-bottomed flask equipped with a septum, magnetic 
stirring bar of dimension 150 mm by 100 mm, and nitrogen inlet was flame-dried and allowed to 
cool.  The flask was charged with (3.03, 3.2 g, 17.8 mmol) and dichloromethane (100 mL).  The 
solution was cooled to –78 °C (bath temperature) in a dry ice/acetone bath, and 
diisobutylaluminum hydride (62.3 mL, 1 M solution in hexanes, 62.3 mmol) was added drop 
wise via syringe in three 20.8 mL portions (approximately 20 min).  During the course of the 
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addition, the solution color became yellow.  The reaction temperature was maintained at –78 °C 
for an additional 45 min, after which time the solution was diluted with dichloromethane (50 
mL) and immediately quenched with a half saturated solution of potassium sodium tartrate (200 
mL), then removed from the dry ice/acetone bath and allowed to warm to rt while stirring 
vigorously.  After 18 h, the reaction was transferred to a separatory funnel, and the organic phase 
was removed and transferred to an Erlenmeyer flask.  The remaining aqueous phase was washed 
with diethyl ether (2 x 50 mL), and the organic layers were transferred to the said Erlenmeyer 
flask and dried over MgSO4, vacuum filtered, and concentrated under reduced pressure.  The off 
white solid was purified by silica gel column chromatography eluting with (20-30% diethyl 
ether/hexanes) to yield compound 3.04 as a white solid (1.9 g, 75%).  Notebook: 01-200, 01-144 
 
Data for 3.0462 
1H NMR (300 MHz, CDCl3)  = 7.29-7.27 (m, 1 H), 7.23-7.21 (m, 1 H), 7.17-7.16 (m, 1 H), 
6.63 (d, J = 15.9 Hz, 1 H), 6.23 (dt, J = 15.9 Hz, 5.7 Hz, 1 H), 4.29 (d, J = 5.7 Hz, 2 H), 1.37 (s, 
1 H). 
13C NMR (300 MHz, CDCl3)  = 139.6, 128.7, 126.4, 125.8, 125.3, 122.6, 64.0 ppm  
TLC (20% diethyl ether/hexanes) Rf  = 0.08 
 
 
(E)-3-(Thiophen-3-yl)allyl 3-phenylpropiolate (3.06).  A single-necked 100 mL round 
bottomed flask equipped with a septum, magnetic stirring bar of dimension 2.5 cm by 1.25 cm, 
and nitrogen inlet was flame-dried and allowed to cool.  The rubber septum was briefly removed, 
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and the flask was charged with (E)-3-(thiophen-3-yl)prop-2-en-1-ol (3.04, 402 mg, 2.9 mmol), 3-
phenylpropiolic acid (3.05, 420 mg, 2.9 mmol), dimethylaminopyridine (53 mg, 0.4 mmol) and 
dry dichloromethane (20 mL) at rt until homogeneous.  The septa was briefly removed and 1-
ethyl-3-(3-dimethylaminopropyl)carbodiimide (825 mg, 4.3 mmol) added in a single portion; 
changing the solution to a clear yellow.  The solution was then stirred at room temperature for 16 
h.  The solution was diluted with dichlorormethane (20 mL) and transferred to a separatory 
funnel.  The organics were washed with deionized water (2 x 25 mL) then sat. brine (25 mL).  
The organic layer was transferred to an Erlenmeyer flask and dried over MgSO4, vacuum 
filtered, and concentrated under reduced pressure.  The residue was purified by silica gel column 
chromatography (25% diethyl ether/hexanes) to yield compound 3.06 as a white waxy solid (557 
mg, 75%).  Notebook: 01-203 
 
Data for 3.06 
1H NMR (400 MHz, CDCl3)  = 7.60-7.58 (m, 2 H), 7.48-7.36 (m, 3 H), 7.29-7.28 (m, 1 H), 
7.24-7.23 (m, 2 H), 6.74 (d, J = 15.6 Hz, 1 H), 6.19 (dt, J = 15.6 Hz, 6.8 Hz, 1 H), 4.86 (d, J = 
6.8 Hz, 2 H). 
13C NMR (500 MHz, CDCl3)  = 153.9, 138.7, 133.0, 129.6, 128.6, 126.3, 125.0, 123.5, 121.8, 
121.8, 119.6, 86.6, 80.5, 66.6 ppm. 
IR (thin film) 
3102, 2947, 2213, 1710, 1659, 1275, 1163, 961, 756, 689 cm-1 
HRMS (FTMS + p APCI) 
[M] calcd for C16H11O2S: 267.0492; found, 267.0469 
TLC (5% ethyl acetate/hexanes) Rf  = 0.4 
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8-Phenylthieno[2,3-f]isobenzofuran-7(5H)-one (3.07a).  (entry 1 Table 2) To a 0.5-2 mL 
microwave vial and equipped with flea stir bar was added diene-yne (3.06, 30 mg, 0.1 mmol) in 
10% nitrobenzene/oDCB (v/v) (1.85 mL) to a final concentration of 0.06 M.  The solution was 
heated for 20 min at 225 °C and cooled to 55 °C.  The reaction solution color changed from 
yellow to dark amber.  The solution was poured directly onto silica plug, and solvent removed 
(10-30% ethyl acetate/hexanes), 3.07a was isolated with (25% ethyl acetate/hexanes) to yield a 
yellow solid (25 mg, 86 %, as a 96:4 ratio of benzo[b]thiophene:dihydrobenzo[b]thiophene).  
Notebook: 02-044, 02-112, 02-117 
 
Data for 3.07a 
1H NMR (500 MHz, CDCl3)  = 7.84 (s, 1 H), 7.74 (d, J = 5.5 Hz, 1 H), 7.61-7.59 (m, 2 H), 
7.55-7.50 (m, 3 H), 7.47 (d, J = 5.5 Hz, 1 H), 5.40 (s, 2 H). 
13C NMR (400 MHz, CDCl3)  = 169.8, 146.0, 142.1, 140.6, 138.6, 134.9, 130.1, 128.7, 128.2, 
127.9, 124.3, 118.9, 114.9, 68.0 ppm 
IR (thin film) 
 3081, 2924, 1759, 1593, 1496, 1356, 1089, 1026 cm-1 
HRMS (TOF MS ES+) 
[M] calcd for C16H10O2S: 266.0402; found 266.0422  
TLC (25% ethyl acetate/hexanes) Rf = 0.3 
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8-Phenyl-4a,5-dihydrothieno[2,3-f]isobenzofuran-7(4H)-one (3.07b).  (entry 1 Table 3) To a 
0.5-2 mL microwave vial and equipped with flea stir bar was added diene-yne (3.06, 22 mg, 0.8 
mmol) in DMF (1.4 mL) to a final concentration of 0.06 M.  The solution was heated for 3 min 
at 225 °C and cooled to 55 °C.  The reaction solution color changed from clear to amber.  The 
solution was diluted with 20 mL ethyl acetate and washed 3 x 20 mL deionized water.  The 
organics were collected and dried with MgSO4, filtered and concentrated under reduced 
pressure to yield brown oil.  The residue was purified by silica gel column chromatography 
(20% ethyl acetate/hexanes), to yield compound 3.07b as a yellow solid (19 mg, 86 %, as a 4:96 
ratio of benzo[b]thiophene:dihydrobenzo[b]thiophene).  Notebook: 01-149, 01-187` 
 
Data for 3.07b 
1H NMR (400 MHz, CDCl3)  = 7.59-7.44 (m, 5 H), 7.42 (d, J = 5.0 Hz, 1 H), 7.02 (d, J = 5.0 
Hz, 1 H), 4.72 (t, J = 8.8 Hz 1 H), 4.05 (t, J = 8.8 Hz, 1 H), 3.66-3.55 (m, 1 H), 3.16 (dd, J = 
15.6 Hz, 8.0 Hz, 1 H), 2.70 (t, J = 16.4 Hz, 1 H). 
Note: 3.07a impurity (s, 7.84), (d, 7.73), (d, 7.59), (s, 5.40 ppm); H Grease impurity 1.26, 0.89 
ppm; H2O impurity 1.58 ppm; unknown 1.69 ppm; dichloromethane 5.30 ppm 
13C NMR (400 MHz, CDCl3)  = 169.8, 146.0, 142.1, 140.6, 138.6, 134.9, 130.1, 128.7, 128.2, 
127.9, 124.3, 118.9, 114.9, 68.0 ppm 
IR (thin film) 
3081, 2924, 1759, 1593, 1496, 1356, 1089, 1026 cm-1 
HRMS (TOF MS ES+) 
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[M] calcd for C16H12O2S: 268.0558; found 268.0576 
TLC (25% ethyl acetate/hexanes) Rf = 0.3 
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Figure 61 Synthetic scheme of thiophene(C2) diene-yne precursor and microwave Diels-Alder reaction 
 
 
Ethyl (E)-3-(thiophen-2-yl)acrylate (3.09).  In a manner entirely analogous to that previously 
reported,56 a single-necked 50 mL round-bottomed flask equipped with a septum, magnetic 
stirring bar of dimension 150 mm by 100 mm, and nitrogen inlet was flame-dried and allowed to 
cool.  The rubber septum was briefly removed, and the flask was charged with sodium hydride 
(66 mg of a 60% dispersion in mineral oil, 2.75 mmol) and dry tetrahydrofuran (30 mL).  The 
mixture was cooled to 0 °C (bath temperature) in an ice bath, and triethyl phosphonoacetate 
(3.01, 0.23 mL, 2.5 mmol) was added drop wise via syringe (approximately 5 min).  After the 
addition was complete, the reaction was stirred at 0 °C for an additional 45 min.  Thiophene-2-
carbaldehyde (3.08, 0.5 mL, 2.5 mmol) was added drop wise via syringe (approximately 5 min).  
During the course of the addition, the solution color became opaque-white.  The reaction 
temperature was maintained at 0 °C for 1.5 h, then removed from the ice bath and allowed to 
warm to rt.  The progress of the reaction was monitored by TLC.  After 17 h, the reaction was 
transferred to a separatory funnel, diluted with diethyl ether (20 mL), and washed with a 
saturated solution of ammonium chloride (2 x 25 mL) and brine (2 x 25 mL).  The organic layer 
was transferred to an Erlenmeyer flask and dried over MgSO4, vacuum filtered, and concentrated 
under reduced pressure.  The residue was purified by silica gel column chromatography (10–50% 
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ethyl acetate/hexanes) to yield compound 3.09 as a colorless oil (216 mg, 89%).  Notebook: 01-
060, 01-173 
 
Data for 3.0956 
1H NMR (300 MHz, CDCl3)  = 7.45 (d, J = 15.6 Hz, 1 H), 7.34 (d, J = 5.1 Hz, 1 H), 7.22 (d, J = 
3.3 Hz, 1 H), 7.01 (dd, J = 5.1 Hz, 3.6 Hz, 1 H), 6.20 (d, J = 15.9 Hz, 1 H), 4.20 (q, J = 7.2 Hz, 2 
H), 1.29 (t, J = 7.2 Hz, 3 H). 
13C NMR (400 MHz, CDCl3)  = 167.0, 139.8, 137.2, 131.0, 128.5, 128.3, 117.3, 60.7, 14.5 
ppm. 
TLC (1% diethyl ether/hexanes) Rf  = 0.25 
 
 
(E)-3-(Thiophen-2-yl)prop-2-en-1-ol (3.10).  In a manner entirely analogous to that previously 
reported,57 a single-necked 25 mL round-bottomed flask equipped with a septum, magnetic 
stirring bar of dimension 150 mm by 100 mm, and nitrogen inlet was flame-dried and allowed 
to cool.  The flask was charged with (3.09, 216 mg, 1.19 mmol) and dichloromethane (10 mL).  
The solution was cooled to –78 °C (bath temperature) in a dry ice/acetone bath, and 
diisobutylaluminum hydride (4.15 mL, 1 M solution in hexanes, 4.15 mmol) was added drop 
wise via syringe (approximately 5 min).  During the course of the addition, the solution color 
became yellow.  The reaction temperature was maintained at –78 °C for an additional 45 min, 
after which time the solution was diluted with dichloromethane (10 mL) and immediately 
quenched with a half saturated solution of potassium sodium tartrate (15 mL), then removed 
from the dry ice/acetone bath and allowed to warm to rt while stirring vigorously.  After 18 h, 
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the reaction was transferred to a separatory funnel, and the organic phase was removed and 
transferred to an Erlenmeyer flask.  The remaining aqueous phase was washed with diethyl 
ether (3 x 10 mL), and the organic layers were transferred to the said Erlenmeyer flask and 
dried over MgSO4, vacuum filtered, and concentrated under reduced pressure.  The residue was 
purified by silica gel column chromatography eluting with (15% ethyl acetate/hexanes) to yield 
compound 3.10 as an opaque-white oil (165 mg, 99%).  Notebook: 01-062, 01-174  
 
Data for 3.1063 
1H NMR (300 MHz, CDCl3)  = 7.15 (t, J = 3 Hz, 1 H), 6.96 (d, J = 3.3 Hz, 2 H), 6.73 (d, 15.6 
Hz, 1 H), 6.16 (dt, J = 15.6 Hz, 5.7 Hz, 1 H), 4.27 (t, J = 5.1 Hz, 2H), 1.42 (t, J = 5.7 Hz, 1 H). 
13C NMR (300 MHz, CDCl3)  = 142.1, 128.5, 127.7, 126.1, 124.7, 124.6, 63.7 ppm 
TLC (15% ethyl acetate/hexanes) Rf  = 0.15 
 
 
(E)-3-(Thiophen-2-yl)allyl 3-phenylpropiolate (3.11).  A single-necked 10 mL round-bottomed 
flask equipped with a septum, magnetic stirring bar of dimension 150 mm by 100 mm, and 
nitrogen inlet was flame-dried and allowed to cool.  The rubber septum was briefly removed, and 
the flask was charged with dimethylaminopyridine (8.7 mg, 0.07 mmol), 3-phenyl propiolic acid 
(3.05, 68.7 mg, 0.47 mmol), and dichloromethane (2 mL) at rt.  (E)-3-(Thiophen-2-yl)prop-2-
en1-ol, (3.10, 66.5 mg, 0.47 mmol) was added to the solution via syringe in dichloromethane (2 
mL).  The rubber septum was briefly removed, and the flask was charged with 
dicyclohexylcarbodiimide (146 mg, 0.7 mmol) during which time the solution turned from 
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colorless to bright yellow.  After 2 h, the solution was poured directly onto silica plug (25 mm 
diameter x 60 mm height) and eluted with diethyl ether.  The residue was collected, 
concentrated, and purified by silica gel column chromatography (30% ethyl acetate/hexanes) to 
yield compound 3.11 as a white solid (86 mg, 68%).  Notebook: 01-085 
 
Data for 3.11 
1H NMR (300 MHz, CDCl3)  = 7.57 (d, J = 7.2 Hz, 2 H), 7.36 (m, J = 7.2 Hz, 1 H), 7.34 (m, J 
= 6.9 Hz, 2 H), 7.18 (d, J = 5.1 Hz, 1 H), 7.00 (d, J = 3 Hz, 1 H), 6.95 (t, J = 4.8 Hz, 3.6 Hz, 1 
H), 6.82 (d, J = 15.6 Hz, 1 H), 6.12 (dt, J = 15.6 Hz, 6.6 Hz, 1 H), 4.85 (d, J = 6.6 Hz, 2 H). 
13C NMR (400 MHz, CDCl3)  = 153.8, 140.9, 133.0, 130.7, 128.6, 128.5, 127.5, 126.9, 125.3, 
121.4, 119.6, 86.7, 80.5, 66.2 ppm 
IR (thin film) 
3067, 2938, 2219, 1708, 1650, 1280, 1185, 955, 758, 689 cm-1 
HRMS (FTMS + p ESI) 
 [M+1] calcd for C16H13O2S: 269.0630; found, 269.0630 
TLC (10% diethyl ether/hexanes) Rf  = 0.24 
 
 
4-Phenylthieno[2,3-f]isobenzofuran-5(7H)-one (3.12a’).  To a 0.5-2 mL microwave vial and 
equipped with flea stir bar was added diene-yne (3.11, 20 mg, 0.074 mmol) in nitrobenzene (1.2 
mL) to a final concentration of 0.06 M.  The solution was heated for 3 min at 225 °C and cooled 
to 55 °C.  The reaction solution color changed from yellow to dark amber.  The solution was 
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poured directly onto silica plug, and nitrobenzene was removed by eluting with (10–30% ethyl 
acetate/hexanes), 3.12a’ was isolated by eluting with (25% diethyl ether/hexanes) to yield a 
yellow solid (18 mg, 90 %).  Notebook: 01-086, 01-141 
 
Data for 3.12a’ 
1H NMR (400 MHz, CDCl3)  = 7.93 (s, 1 H), 7.51-7.47 (m, 6 H), 7.28 (d, J = 5.6 Hz, 1 H), 
5.39 (s, 2 H). 
Note Impurities: silicone grease (0.11-0.05); H Grease (s, 1.26), (b, 0.90-0.87); H2O (s, 1.57) 
13C NMR (400 MHz, CDCl3)  = 169.8, 146.0, 142.1, 140.5, 138.5, 134.9, 130.1, 128.7, 128.2, 
127.9, 124.3, 118.89, 114.9, 68.1 ppm. 
IR (thin film) 
3108, 2923, 1759, 1593, 1496, 1450, 1356, 1088, 1025 cm-1 
(TOF MS ES+) 
[M] calcd for C16H10O2S: 266.0402; found 266.0423 
TLC (25% diethyl ether/hexanes) Rf  = 0.1 
 
 
4-Phenyl-7a,8-dihydrothieno[2,3-f]isobenzofuran-5(7H)-one (3.12b’).  (entry 2 Table 3) To 
a 0.5-2 mL microwave vial and equipped with flea stir bar was added diene-yne (3.11, 23.6 mg, 
0.088 mmol) in dimethylformamide (1.5 mL) to a final concentration of 0.06 M.  The solution 
was heated for 3 min at 225 °C and cooled to 55 °C.  The reaction solution color changed from 
clear to amber.  The reaction was diluted with ethyl acetate (10 mL) and washed with deionized 
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water (3 x 10 mL).  The organic layer was transferred to an Erlenmeyer flask and dried over 
MgSO4, vacuum filtered, and concentrated under reduced pressure.  The residue was purified by 
silica gel column chromatography (25% diethyl ether/hexanes) to yield compound 3.12b’ as a 
white waxy solid (14 mg, 58 % as a 3:97 ratio of 
benzo[b]thiophene:dihydrobenzo[b]thiophene).  Notebook: 01-084 
 
Data for 3.12b’ 
1H NMR (400 MHz, CDCl3)  = 7.42 (s, 3 H), 7.38 (d, J = 3.2 Hz, 2 H), 7.08 (d, J = 5.2 Hz, 1 
H), 6.72 (d, J = 5.2 Hz, 1 H), 4.70 (t, J = 8.8 Hz, 1 H), 4.03 (t, J = 8.8 Hz, 1 H), 3.70-3.60 (m, J 
= 8.8 Hz, 1 H), 3.20 (dd, J = 15.6 Hz, 7.6 Hz, 1 H), 2.80 (t, J = 16.4 Hz, 1 H). 
Note Impurities: silicone grease (.08); H Grease (s, 1.26), (b 0.88, 0.89); H2O (s, 1.57); 
dichloromethane (s, 5.30); 3.12a’ (s, 5.39) 
13C NMR (400 MHz, CDCl3)  = 168.1, 144.3, 139.3, 138.2, 134.4, 129.5, 128.9, 127.9, 126.9,  
123.0, 117.7, 70.6, 37.6, 27.9 ppm 
IR (thin film) 
3120, 2898, 1746, 1631, 1506, 1220, 1094, 1008 cm-1 
LRMS (TOF MS ES+) 
m/z (%): 270 (29), 269 (100), 268 (48), 224 (15), 223 (58) 
HRMS (TOF MS ES+) 
[M+1] calcd for C16H13O2S: 269.0636; found, 269.0661 
TLC (25% diethyl ether/hexanes) Rf  = 0.07 
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Figure 62 Synthetic scheme of furan(C3) diene-yne precursor and microwave Diels-Alder reaction 
 
 
Ethyl (E)-3-(furan-3-yl)acrylate (3.16).  In a manner entirely analogous to that previously 
reported,59 a double-necked 50 mL round-bottom flask equipped with a septum, reflux 
condenser, magnetic stirring bar of dimension 300 mm by 150 mm, and nitrogen inlet was flame 
dried and allowed to cool.  The flask was charged with ethyl 2-(triphenyl-5-
phosphanylidene)acetate, (3.14, 1.54g, 4.4 mmol) and tetrahydrofuran (20 mL).58  The solution 
was heated to reflux in an oil bath.  Once the solution was at reflux, a solution of (3.15, 0.35 mL, 
4.0 mmol) in tetrahydrofuran (0.35 mL) was added drop wise via syringe (approximately 5 min).  
After the addition was complete, the reflux was maintained for 2 h then removed from the oil 
bath and allowed to cool to rt.  The solution was concentrated under reduced pressure to yield a 
tan solid.  The residue was purified by silica gel column chromatography (50% 
dichloromethane/hexanes; 5%-10% diethyl ether/hexanes) to yield compound 3.16 as a white 
solid (549 mg, 83%).  Notebook: 01-095 
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Data for 3.1659 
1H NMR (300 MHz, CDCl3)  = 7.64 (d, J = 0.6 Hz, 1 H), 7.55 (d, J = 15.9 Hz, 1 H), 7.43-7.42 
(m, 1 H), 6.58 (t, J = 1.2 Hz, 0.6 Hz, 1 H), 6.13 (d, J = 15.9 Hz, 1 H), 4.21 (q, J = 7.2 Hz, 6.9 Hz, 
2 H), 1.30 (t, J = 7.2 Hz, 6.9 Hz, 3 H). 
13C NMR (400 MHz, CDCl3)  = 166.8, 144.2, 144.1, 134.3, 122.4, 117.9, 107.2, 60.2, 14.1 
ppm. 
TLC (10% diethyl ether/hexanes) Rf  = 0.4 
 
 
(E)-3-(Furan-3-yl)prop-2-en-1-ol (3.17).  In a manner entirely analogous to that previously 
reported,59 a single-necked 25 mL round-bottom flask equipped with a septum, magnetic stirring 
bar of dimension 300 mm by 100 mm, and nitrogen inlet was flame-dried and allowed to cool.  
The flask was charged with lithium aluminum hydride (114 mg, 3.0 mmol) and placed under 
vacuum for 20 min then flushed with nitrogen for 20 min.  The flask was cooled to 0 °C (bath 
temperature) in water/ice bath, and diethyl ether (5 ml) was added to the flask.  Once the solution 
was cooled, (3.16, 166 mg, 1.0 mmol) was added drop wise via syringe (approximately 5 min) in 
a minimum volume of diethyl ether.  During the course of the addition, gas evolution was 
observed.  Once the addition of 3.16 was complete, the ice bath was removed and the reaction 
was allowed to warm to rt.  After 1 h at rt, the reaction temperature was lowered to 0 °C, and the 
excess hydride was quenched via drop wise addition of water/tetrahydrofuran (10 mL, 7.5% v/v).  
During the course of the addition, gas evolution was observed.  The resulting mixture was 
filtered over celite, and the filter cake was washed with diethyl ether.  The resulting solution was 
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dried over MgSO4, vacuum filtered, and concentrated under reduce pressure to yield compound 
3.17 (124 mg, 100% yield) as a clear oil.  3.17 was used in the next step without further 
purification.  Notebook: 01-099, 01-168 
 
Data for 3.1759 
1H NMR (300 MHz, CDCl3)  = 7.36 (d, J = 4.2 Hz, 1 H), 7.33 (s, 1 H), 6.49 (t, J = 0.9 Hz, 0.6 
Hz, 1 H), 6.40 (d, J = 15.6 Hz, 1 H), 6.00 (dt, J = 15.6 Hz, 5.7 Hz, 1 H), 4.19 (dd, J = 5.7 Hz, 1.2 
Hz, 2 H), 2.85 (s, b, 1 H). 
13C NMR (400 MHz, CDCl3)  = 143.5, 140.5, 128.2, 123.7, 120.9, 107.6, 63.3 ppm. 
 
 
(E)-3-(Furan-3-yl)allyl 3-phenylpropiolate (3.18).  A single-necked 10 mL round-bottomed 
flask equipped with a septum, magnetic stirring bar of dimension 150 mm by 100 mm, and 
nitrogen inlet was flame-dried and allowed to cool.  The rubber septum was briefly removed, and 
the flask was charged with dimethylaminopyridine (18.3 mg, 0.15 mmol), 3-phenyl propiolic 
acid (3.05, 146 mg, 1 mmol), and dichloromethane (2 mL) at rt.  (E)-3-(Furan-2-yl)prop-2-en-1ol 
(3.17, 124 mg, 1 mmol) was added to the solution via syringe in dichloromethane (2 mL).  The 
rubber septum was briefly removed, and the flask was charged with dicyclohexylcarbodiimide 
(310 mg, 1.5 mmol) during which time the solution turned from colorless to brown.  After 3 h, 
the solution was poured directly onto silica plug (25 mm diameter x 65 mm height) and eluted 
with diethyl ether.  The residue was collected, concentrated, and purified by silica gel column 
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chromatography (5% diethyl ether/hexanes) to yield compound 3.18 as a white solid (169 mg, 
67%).  Notebook: 01-101, 01-172 
 
Data for 3.18 
1H NMR (300 MHz, CDCl3)  = 7.57 (d, J = 6.8 Hz, 2 H), 7.46-7.36 (m, 5 H), 6.58 (d, J = 15.9, 
1H), 6.54 (d, J = 1.2 Hz, 1 H), 6.02 (dt, J = 15.9 Hz, 6.9 Hz, 1 H), 4.82 (dd, J = 6.9 Hz, 1.2Hz, 1 
H). 
13C NMR (400 MHz, CDCl3)  = 153.8, 140.9, 133.0, 130.7, 128.6, 128.5, 127.5, 126.9, 125.3, 
121.4, 119.6, 86.7, 80.5, 66.2 ppm 
IR (thin film) 
3143, 3059, 2951, 2220, 1704, 1667, 1283, 1170, 963, 758, 689 cm-1 
LRMS (TOF MS ES+) 
m/z (%): 253 (17), 252 (100), 251 (18), 225 (12), 223 (20), 213 (10), 208 (12), 207 (11) 
HRMS (TOF MS ES+) 
[M] calcd for C16H12O3: 252.0786; found, 252.0785 
TLC (5% diethyl ether/hexanes) Rf  = 0.14 
 
 
8-Phenylbenzo[1,2-b:4,5-c']difuran-7(5H)-one (3.19a).  To a 0.5-2 mL microwave vial and 
equipped with flea stir bar was added diene-yne (3.18, 14 mg, 0.055 mmol) in nitrobenzene (0.9 
mL) to a final concentration of 0.06 M.  The solution was heated for 3 min at 225 °C and cooled 
to 55 °C.  The reaction solution color changed from yellow to dark amber.  The solution was 
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poured directly onto silica plug, and nitrobenzene was removed (10-30% ethyl acetate/hexanes), 
3.19a was isolated with (25% diethyl ether/hexanes) to yield an off-white solid (12 mg, 78 %).  
Notebook: 01-105, 01-139, 01-181, 01-182 
 
Data for 3.19a 
1H NMR (300 MHz, CDCl3)  = 7.82 (d, J = 2.4 Hz, 1 H), 7.65 (dd, J = 8.1 Hz, 1.8Hz, 2 H), 
7.60 (s, 1 H), 7.56-7.48 (m, 3 H), 6.91 (d, J = 2.4 Hz, 1 H), 5.36 (s, 2 H). 
Note Impurities: H Grease (t, 1.26); H2O (s, 1.54); acetone (s, 2.05); dichloromethane (s, 5.30) 
13C NMR (400 MHz, CDCl3)  = 170.1, 153.0, 149.6, 142.0, 133.9, 130.7, 130.5, 129.0, 128.1, 
126.8, 118.3, 112.9, 107.11, 68.2 ppm  
IR (thin film)  
2914, 1751, 1610, 1476, 1348, 1260, 1132 cm-1  
LRMS (TOF MS ES+)  
m/z (%): 251 (40), 250 (100), 249 (43), 221 (53)  
HRMS (TOF MS ES+) 
[M] calcd for C16H10O3: 250.0630; found 250.0608  
TLC (25% diethyl ether/hexanes) Rf  = 0.08 
 
 
8-Phenyl-4a,5-dihydrobenzo[1,2-b:4,5-c']difuran-7(4H)-one (3.19b).  (entry 3 Table 3) To a 
0.5-2 mL microwave vial and equipped with flea stir bar was added diene-yne (3.18, 14 mg, 
0.055 mmol) in dimethylformamide (0.9 mL) to a final concentration of 0.06 M.  The solution 
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was heated for 3 min at 225 °C and cooled to 55 °C.  The reaction solution color changed from 
clear to amber.  The reaction was diluted with ethyl acetate (10 mL) and washed with deionized 
water (3 x 10 mL).  The organic layer was transferred to an Erlenmeyer flask and dried over 
MgSO4, vacuum filtered, and concentrated under reduced pressure.  The residue was purified by 
silica gel column chromatography (25% diethyl ether/hexanes) to yield compound 3.19b as a 
white waxy solid (5 mg, 36 % as a 12:88 ratio of benzo[b]furan:dihydrobenzo[b]furan).  
Notebook: 01-104, 01-179, 01-180 
 
Data for 3.19b 
1H NMR (400 MHz, CDCl3)  = 7.55-7.51 (m, 3 H), 7.49-7.43 (m, 3 H), 6.46 (d, J = 1.6 Hz, 1 
H), 4.68 (t, J = 8.8 Hz, 1 H), 4.01 (t, J = 9.2 Hz, 1 H), 3.69-3.63 (m, J = 9.2 Hz, 1 H), 2.93 (dd, 
J = 16 Hz, 9.2 Hz, 1 H), 2.60 (t, J = 16 Hz, 1 H). 
Note Impurities: H Grease (s, 1.26); H2O (b, 1.56); dichloromethane (s, 5.30); 3.19a (d, 7.83), 
(d, 7.66), (s, 7.61), (d, 6.91), (s, 5.37)   
13C NMR (400 MHz, CDCl3)  = 168.7, 151.9, 146.0, 139.5, 131.2, 130.9, 130.6, 130.0, 128.5, 
128.3, 124.4, 117.0, 112.0, 71.2, 38.6, 25.7 ppm.   
IR (thin film)  
2920, 1737, 1620, 1556, 1468, 1257, 1096 cm-1  
LRMS (TOF MS ES+)  
m/z (%): 268 (18), 253 (100), 252 (50), 251 (60), 250 (64), 221 (17), 208 (19), 207 (55)  
HRMS (TOF MS ES+)  
[M+1] calcd for C16H13O3: 253.0865; found 253.0888  
TLC (25% diethyl ether/hexanes) Rf = 0.07  
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Figure 63 Synthetic scheme of furan(C2) diene-yne precursor and microwave Diels-Alder reaction 
 
 
Ethyl (E)-3-(furan-2-yl)acrylate (3.21).  In a manner entirely analogous to that previously 
reported,59 a double-necked 50 mL round-bottom flask equipped with a septum, reflux condenser, 
magnetic stirring bar of dimension 150 mm by 100 mm, and nitrogen inlet was flame-dried and 
allowed to cool.  The flask was charged with ethyl 2-(triphenylphosphanylidene)acetate, 
(3.15, 1.54g, 4.4 mmol) and tetrahydrofuran (20 mL).58  The solution was heated to reflux in an 
oil bath.  Once the solution was at reflux, a solution of (3.20, 0.35 mL, 4 mmol) in 
tetrahydrofuran (0.35 mL) was added drop wise via syringe (approximately 5 min).  After the 
addition was complete, the reflux was maintained for 2 h then removed from the oil bath and 
allowed to cool to rt.  The solution was concentrated under reduced pressure to yield a tan solid.  
The residue was purified by silica gel column chromatography (50% dichloromethane/hexanes; 
5%–10% diethyl ether/hexanes) to yield compound 3.21 as a clear liquid (552 mg, 83%).  
Notebook: 01-108 
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Data for 3.2164  
1H NMR (300 MHz, CDCl3)  = 7.47 (t, J = 1.5 Hz, 0.9 Hz, 1 H), 7.40 (d, J = 15.6 Hz, 1 H), 
6.59 (d, J = 3.3 Hz, 1 H), 6.45 (dd, J = 3.6 Hz, 1.8 Hz, 1 H), 6.28 (d, J = 15.6 Hz, 1 H), 4.20 (q, 
J = 7.2 Hz, 6.9 Hz, 2 H), 1.29 (t, J = 7.2 Hz, 6.9 Hz, 3 H).  
13C NMR (400 MHz, CDCl3)  = 167.3, 151.3, 145.0, 131.3, 116.3, 114.9, 112.5, 60.7, 14.6 
ppm.  
TLC (5% diethyl ether/hexanes) Rf  = 0.38 
 
 
(E)-3-(Furan-2-yl)prop-2-en-1-ol (3.22).  In a manner entirely analogous to that previously 
reported,57 a single-necked 250 mL round-bottomed flask equipped with a septum, magnetic 
stirring bar of dimension 150 mm by 100 mm, and nitrogen inlet was flame-dried and allowed to 
cool.  The flask was charged with (3.21, 500 mg, 3.0 mmol) and dichloromethane (60 mL).  The 
solution was cooled to –78 °C (bath temperature) in a dry ice/acetone bath, and 
diisobutylaluminum hydride (7.5 mL, 1 M solution in hexanes, 7.5 mmol) was added drop wise 
via syringe (approximately 5 min).  During the course of the addition, the solution color became 
yellow.  The reaction temperature was maintained at –78 °C for an additional 2.5 h, after which 
time the solution was diluted with dichloromethane (30 mL) and immediately quenched with a 
half saturated solution of potassium sodium tartrate (90 mL), then removed from the dry 
ice/acetone bath and allowed to warm to rt while stirring vigorously.  After 16 h, the reaction 
was transferred to a separatory funnel, and the organic phase was removed and transferred to an 
Erlenmeyer flask.  The remaining aqueous phase was washed with dichloromethane (3 x 25 mL), 
and the organic layers were transferred to the said Erlenmeyer flask and dried over MgSO4, 
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vacuum filtered, and concentrated under reduced pressure to yield a yellow oil.  The oil was 
purified by silica gel column chromatography eluting with (30% ethyl acetate/hexanes) to yield 
3.22 (303 mg, 81% yield) as a yellow oil.  Notebook: 02-158 
 
Data for 3.2265 
1H NMR (300 MHz, CDCl3)  = 7.35 (s, 1 H), 6.48-6.24 (m, 4 H), 4.30 (s, 2 H), 1.47 (b, 1 H).  
Note Impurities: H Grease (s, 1.26), (0.85)  
13C NMR (300 MHz, CDCl3)  = 152.6, 142.1, 127.5, 119.3, 111.4, 108.1, 63.2 ppm. 
TLC (30% ethyl acetate/hexanes) Rf  = 0.3 
 
 
(E)-3-(Furan-2-yl)allyl 3-phenylpropiolate (3.23).  A single-necked 25 mL round-bottomed 
flask equipped with a septum, magnetic stirring bar of dimension 150 mm by 100 mm, and 
nitrogen inlet was flame-dried and allowed to cool.  The rubber septum was briefly removed, and 
the flask was charged with dimethylaminopyridine (9.4 mg, 0.08 mmol), 3-phenyl propiolic acid 
(3.05, 74.5 mg, 0.5 mmol), and dichloromethane (3 mL) at rt.  (E)-3-(Furan-2-yl)prop-2-en-1-ol, 
(3.22, 63 mg, 0.5 mmol) was added to the solution via syringe in dichloromethane (2 mL).  The 
rubber septum was briefly removed, and the flask was charged with 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide (147 mg, 0.77 mmol).  The solution turned from colorless to 
light brown.  After 20 h, the reaction was concentrated under reduced pressure.  The residue was 
purified by silica gel column chromatography (10-20% diethyl ether /hexanes) to yield 
compound 3.23 as a clear oil (103 mg, 80%).  Notebook: 01-120, 01-185 
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Data for 3.23  
1H NMR (400 MHz, CDCl3)  = 7.60 (s, 1 H), 7.58 (d, J = 3.6 Hz, 1 H), 7.48-7.44 (m, 1H), 
7.40-7.36 (m, 3 H), 6.52 (d, J = 16 Hz, 1 H), 6.38 (dd, J = 3.2, Hz, J = 1.6 Hz, 1 H), 6.32 (d, J = 
3.2 Hz, 1 H), 6.22 (dt, J = 16 Hz, 6.4 Hz, 1 H), 4.85 (dd, J = 6.8 Hz, 1.2Hz, 1 H).  
13C NMR (400 MHz, CDCl3)  = 154.1, 152.0, 142.9, 133.4, 131.0, 128.9, 123.5, 120.9, 119.9, 
111.7, 109.6, 87.0, 80.8, 66.4 ppm.  
IR (thin film)  
3059, 2960, 2922, 2217, 1706, 1260, 1167, 1100, 1016, 957, 755, 687 cm-1  
HRMS (FTMS + pESI)  
[M+1] calcd for C16H13O3: 253.08592; found 253.08588  
TLC (20% diethyl ether/hexanes) Rf  = 0.45 
 
 
4-Phenylbenzo[1,2-b:4,5-c']difuran-5(7H)-one (3.24a’).  To a 0.5-2 mL microwave vial and 
equipped with flea stir bar was added diene-yne (3.23, 26 mg, 0.1 mmol) in nitrobenzene (1.7 
mL) to a final concentration of 0.06 M.  The solution was heated for 3 min at 225 °C and cooled 
to 55 °C.  The reaction solution color changed from yellow to dark amber.  The solution was 
poured directly onto silica plug, and nitrobenzene was removed (10-30% ethyl acetate/hexanes), 
3.24a’ was isolated with (25% diethyl ether/hexanes) to yield an off-white solid (17 mg, 65 %). 
Notebook: 01-134, 01-140 
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Data for 3.24a’ 
1H NMR (400 MHz, CDCl3)  = 7.72 (d, J = 2.4 Hz, 1 H), 7.57-7.45 (m, 6 H), 6.82 (d, J = 1.2 
Hz, 1 H), 5.38 (s, 2 H).  
Note Impurities: silicone grease (.08); H Grease (s, 1.26); H2O (s, 1.59); dichloromethane (s, 
5.30)  
13C NMR (400 MHz, CDCl3)  = 169.8, 158.1, 147.2, 144.3, 136.7, 134.1, 130.1, 129.5, 128.7, 
128.2, 116.8, 107.0, 104.6, 68.1 ppm.  
IR (thin film)  
3121, 3059, 1753, 1593, 1539, 1477, 1293, 1104, 1026 cm-1 
LRMS (TOF MS ES+)  
m/z (%): 251 (65), 250 (100), 249 (12), 222 (10), 221 (61)  
HRMS (TOF MS ES+)  
[M] calcd for C16H10O3: 250.0630; found 250.0607  
TLC (25% diethyl ether/hexanes) Rf  = 0.12 
 
 
4-Phenyl-7a,8-dihydrobenzo[1,2-b:4,5-c']difuran-5(7H)-one (3.24b’).  (entry 4 Table 3) To 
a 0.5-2 mL microwave vial and equipped with flea stir bar was added diene-yne (3.23, 23 mg, 
0.09 mmol) in dimethylformamide (1.5 mL) to a final concentration of 0.06 M.  The solution 
was heated for 3 min at 225 °C and cooled to 55 °C.  The reaction solution color changed from 
clear to amber.  The reaction was diluted with ethyl acetate (10 mL) and washed with deionized 
water (3 x 10 mL).  The organic layer was transferred to an Erlenmeyer flask and dried over 
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MgSO4, vacuum filtered, and concentrated under reduced pressure.  The residue was purified by 
silica gel column chromatography (25% diethyl ether/hexanes) to yield compound 3.24b’ as a 
white waxy solid (9 mg, 41 % as a 5:95 ratio of benzo[b]furan:dihydrobenzo[b]furan).  
Notebook: 01-133 
 
Data for 3.24b’    
1H NMR (400 MHz, CDCl3)  = 7.45-7.41 (m, 5 H), 7.34 (s, 1 H), 6.27 (d, J = 1.6 Hz, 1 H), 
4.70 (t, J = 8.8 Hz, 1 H), 4.03 (t, J = 9.2 Hz, 1 H), 3.82-3.71 (m, J = 9.2 Hz, 1 H), 3.10 (dd, J = 
16.4 Hz, 9.6 Hz, 1 H), 2.76 (t, J = 16.8 Hz, 1 H).  
Note Impurities: H Grease (s, 1.26), (b, 0.89-0.84); H2O (s, 1.56); dichloromethane (s, 5.30)  
13C NMR (400 MHz, CDCl3)  = 167.8, 154.4, 144.2, 142.9, 133.7, 129.4, 129.3, 127.9, 122.1, 
114.6, 109.2, 70.6, 38.5, 26.5 ppm.  
IR (thin film)  
3124, 2936, 2860, 1741, 1633, 1568, 1251, 1091, 1015 cm-1  
LRMS (TOF MS ES+)  
m/z (%): 268 (18), 253 (100), 252 (49), 251 (54), 250 (53), 221 (13), 208 (19), 207 (51)  
HRMS (TOF MS ES+)  
[M+1] calcd for C16H13O3: 253.0865; found 253.0892  
TLC (25% diethyl ether/hexanes) Rf  = 0.08 
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(E)-3-(Thiophen-3-yl)allyl 3-(trimethylsilyl)propiolate (3.26).  A single-necked 25 mL 
round-bottomed flask equipped with a septum, magnetic stirring bar of dimension 150 mm by 
100 mm, and nitrogen inlet was flame-dried and allowed to cool.  The rubber septum was 
briefly removed, and the flask was charged with (E)-3-(thiophen-3-yl)prop-2-en-1-ol (3.04, 140 
mg, 1.0 mmol), 3-(trimethylsilyl)propiolic acid (3.25, 213 mg, 1.5 mmol), 
dimethylaminopyridine (49 mg, 0.4 mmol) and dry dichloromethane (8 mL) at rt until 
homogeneous.  The solution was then cooled to –78 °C (bath temperature) in a dry ice/acetone 
bath.  The septa was briefly removed and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (230 
mg, 1.2 mmol) added in a single portion.  The solution was slowly warmed to 0 °C over the 
course or 6 h.  The solution was diluted with dichlorormethane (20 mL) and transferred to a 
separatory funnel.  The organics were washed with deionized water (2 x 25 mL) then sat. brine 
(25 mL).  The organic layer was transferred to an Erlenmeyer flask and dried over MgSO4, 
vacuum filtered, and concentrated under reduced pressure.  The residue was purified by silica 
gel column chromatography (5-10% ethyl acetate/hexanes) to yield compound 3.26 as a clear 
oil (192 mg, 70 %).  Notebook: 02-062, 02-098 
 
Data for 3.26   
1H NMR (400 MHz, CDCl3)  = 7.34-7.31 (m, 1 H), 7.26-7.25 (m, 2 H), 6.74 (d, J = 15.6 Hz, 1 
H), 6.18 (dt, J = 15.6 Hz, 6.8 Hz, 1 H), 4.83 (d, J = 6.8 Hz, 2 H), 0.30 (s, 9 H).  
13C NMR (400 MHz, CDCl3)  = 153.1, 138.9, 130.0, 126.6, 125.2, 123.8, 122.0, 94.7, 94.6, 
66.8, -0.6 ppm.  
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IR (thin film) 
3101, 2961, 2176, 1710, 1658, 1451, 1252, 1216, 964, 848, 763 cm-1 
HRMS (FTMS + p ESI) 
[M] calcd for C13H15O2SSi: 263.0556; found, 263.0561 
TLC (20% ethyl acetate/hexanes) Rf  = 0.8 
 
 
8-(Trimethylsilyl)-5,6-dihydro-7H-thieno[2,3-f]isoindol-7-one (3.27a).  (entry 2 Table 2) To 
a 0.5-2 mL microwave vial and equipped with flea stir bar was added diene-yne (3.26, 32 mg, 
0.1 mmol) in 10% nitrobenzene/oDCB (v/v) (2.0 mL) to a final concentration of 0.06 M.  The 
solution was heated for 20 min at 225 °C and cooled to 55 °C.  The reaction solution color 
changed from yellow to dark amber.  The solution was poured directly onto silica plug, and 
solvent removed (10-50% ethyl acetate/hexanes), 3.27a was isolated with (10-20% ethyl 
acetate/hexanes) to yield a white solid (25 mg, 71 %, as a 99:1 ratio of 
benzo[b]thiophene:dihydrobenzo[b]thiophene).  Notebook: 02-083, 02-092, 02-093 
 
Data for 3.27a 
1H NMR (500 MHz, CDCl3)  = 7.85 (s, 1 H), 7.74 (d, J = 5.7 Hz, 1 H), 7.41 (d, J = 5.7 Hz, 1 
H), 5.38 (s, 2 H), 0.61 (s, 9 H). 
H2O impurity 1.57 ppm 
13C NMR (500 MHz, CDCl3)  = 172.4, 147.4, 143.3, 142.3, 137.6, 132.2, 127.2, 123.2, 117.5, 
69.0, 1.7 ppm 
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IR (thin film) 
3094, 2954, 2898, 1756, 1591, 1455, 1354, 1304, 1245, 1190, 1154, 1088, 1067, 895, 
844, 792, 741, 701, 629 cm-1 
HRMS (FTMS + p ESI)  
[M+1] calcd for C13H15O2SSi: 263.0556; found 263.0561  
TLC (25% ethyl acetate/hexanes) Rf = 0.2 
 
 
4a,5-Dihydrothieno[2,3-f]isobenzofuran-7(4H)-one (3.27b).  (entry 5 Table 3) To a 0.5-2 mL 
microwave vial and equipped with flea stir bar was added diene-yne (3.26, 31 mg, 0.1 mmol) in 
DMF (1.95 mL) to a final concentration of 0.06 M.  The solution was heated for 3 min at 225 °C 
and cooled to 55 °C.  The reaction solution color changed from clear to amber.  The solution was 
diluted with 20 mL ethyl acetate and washed 3 x 20 mL deionized water.  The organics were 
collected and dried with MgSO4, filtered and concentrated under reduced pressure to yield brown 
oil.  The residue was purified by silica gel column chromatography (20% ethyl acetate/hexanes), 
to yield compound 3.27b as a white waxy solid (11 mg, 48 %, as a 12:88 ratio of 
benzo[b]thiophene:dihydrobenzo[b]thiophene).  Notebook: 02-137, 02-135 
 
Data for 3.27b 
1H NMR (500 MHz, CDCl3)  = 7.45-7.42 (m, 2 H), 6.98 (d, J = 4.8 Hz 1 H), 4.76 (t, J = 9.0 Hz, 
1 H), 4.05 (t, J = 9.0 Hz, 1 H), 3.47-3.37 (m, 1 H), 3.16 (dd, J = 15.5 Hz, 8.5 Hz, 1 H), 2.60 (t, J 
= 16.0 Hz, 1 H). 
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Note: Aromatic impurity (s, 8.46), (s, 7.88), (d, 7.77), (s, 5.43 ppm); H Grease impurity 1.26, 
0.89 ppm; H2O impurity 1.57 ppm; unknown 3.36, 2.36 ppm; dichloromethane 5.30 ppm   
13C NMR (500 MHz, CDCl3)  = 169.5, 138.3, 134.2, 128.9, 127.6, 126.7, 124.4, 72.5, 36.1, 
28.6 ppm  
Note: Aromatic impurity 132.4, 123.8, 121.0, 116.8, 69.7, 30.0 ppm  
IR (thin film)  
3122, 2997, 2921, 2895, 1741, 1637, 1506, 1472, 1377, 1290, 1268, 1238, 1173, 1073, 
1043, 983, 939, 909, 731 cm-1  
HRMS (FTMS + p ESI) 
[M+1] calcd for C10H9O2S: 193.0318; found 193.0313  
TLC (20% ethyl acetate/hexanes) Rf = 0.3 
 
 
(E)-3-(Thiophen-2-yl)allyl 3-(trimethylsilyl)propiolate (3.28).  A single-necked 25 mL round-
bottomed flask equipped with a septum, magnetic stirring bar of dimension 150 mm by 100 mm, 
and nitrogen inlet was flame-dried and allowed to cool.  The rubber septum was briefly removed, 
and the flask was charged with (E)-3-(thiophen-2-yl)prop-2-en-1-ol (3.10, 205 mg, 1.5 mmol), 3-
(trimethylsilyl)propiolic acid (3.25, 213 mg, 1.5 mmol), dimethylaminopyridine (27 mg, 0.2 
mmol) and dry dichloromethane (5 mL) at rt until homogeneous.  The solution was then cooled 
to –78 °C (bath temperature) in a dry ice/acetone bath.  The septa was briefly removed and 1-
ethyl-3-(3-dimethylaminopropyl)carbodiimide (420 mg, 2.2 mmol) added in a single portion.  
The solution was slowly warmed to 0 °C over the course or 6 h.  The solution was diluted with 
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dichlorormethane (15 mL) and transferred to a separatory funnel.  The organics were washed 
with deionized water (2 x 20 mL) then sat. brine (20 mL).  The organic layer was transferred to 
an Erlenmeyer flask and dried over MgSO4, vacuum filtered, and concentrated under reduced 
pressure.  The residue was purified by silica gel column chromatography (20% 
dichloromethane/hexanes) to yield compound 3.28 as a clear oil (155 mg, 40 %).  Notebook: 02-
134 
 
Data for 3.28 
1H NMR (500 MHz, CDCl3)  = 7.20 (d, J = 5.0 Hz 1 H), 7.01-7.00 (m, 1 H), 6.98-6.96 (m, 1 
H), 6.82 (d, J = 15.7 Hz, 1 H), 6.12 (dt, J = 15.7 Hz, 6.5 Hz, 1 H), 4.78 (d, J = 6.5 Hz, 2 H), 
0.25 (s, 9 H).  
13C NMR (500 MHz, CDCl3)  = 153.1, 141.2, 128.9, 127.8, 127.2, 125.6, 121.6, 94.8, 94.7, 
66.5, -0.6 ppm.  
IR (thin film)  
3104, 2960, 2175, 1710, 1657, 1449, 1252, 1216, 964, 848, 763 cm-1   
HRMS (FTMS + p ESI)  
[M+1] calcd for C13H17O2SSi: 265.0713; found, 265.0698  
TLC (5% ethyl acetate/hexanes) Rf  = 0.2 
 
 
4-(Trimethylsilyl)thieno[2,3-f]isobenzofuran-5(7H)-one (3.29a’).  (entry 3 Table 2) To a 0.5-
2 mL microwave vial and equipped with flea stir bar was added diene-yne (3.28, 31 mg, 0.12 
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mmol) in 10% nitrobenzene/oDCB (v/v) (1.9 mL) to a final concentration of 0.06 M.  The 
solution was heated for 20 min at 225 °C and cooled to 55 °C.  The reaction solution color 
changed from yellow to dark amber.  The solution was poured directly onto silica plug, and 
solvent removed (10-50% ethyl acetate/hexanes), 3.29a’ was isolated with (10-15% ethyl 
acetate/hexanes) to yield a white solid (27 mg, 86 %, as a 100:0 ratio of 
benzo[b]thiophene:dihydrobenzo[b]thiophene).  Notebook: 02-138, 02-139 
 
Data for 3.29a’ 
1H NMR (500 MHz, CDCl3)  = 7.96 (s, 1 H), 7.89 (d, J = 6.0 Hz, 1 H), 7.58 (d, J = 6.0 Hz, 1 
H), 5.38 (s, 2 H), 0.58 (s, 9 H).  
H2O impurity 1.54 ppm  
13C NMR (500 MHz, CDCl3)  = 171.8, 145.6, 145.4, 141.6, 139.0, 128.2, 127.7, 126.3, 116.8, 
68.8, 2.4 ppm  
IR (thin film)  
3110, 2944, 2897, 1756, 1586, 1443, 1417, 1360, 1240, 1164, 1089, 1023, 978, 886, 
847, 771, 704, 689 cm-1  
HRMS (FTMS + p ESI)  
[M+1] calcd for C13H15O2SSi: 263.0556; found 263.0553  
TLC (20% ethyl acetate/hexanes) Rf = 0.2 
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(E)-3-(Furan-2-yl)allyl 3-(trimethylsilyl)propiolate (3.30).  A single-necked 25 mL round-
bottomed flask equipped with a septum, magnetic stirring bar of dimension 150 mm by 100 
mm, and nitrogen inlet was flame-dried and allowed to cool.  The rubber septum was briefly 
removed, and the flask was charged with (E)-3-(furan-2-yl)prop-2-en-1-ol (3.22, 150 mg, 1.2 
mmol), 3-(trimethylsilyl)propiolic acid (3.25, 172 mg, 1.2 mmol), dimethylaminopyridine (22 
mg, 0.2 mmol) and dry dichloromethane (7 mL) at rt until homogeneous.  The solution was then 
cooled to –78 °C (bath temperature) in a dry ice/acetone bath.  The septa was briefly removed 
and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (347 mg, 1.8 mmol) added in a single 
portion.  The solution was slowly warmed to 0 °C over the course or 5 h.  The solution was 
diluted with dichlorormethane (15 mL) and transferred to a separatory funnel.  The organics 
were washed with deionized water (2 x 20 mL) then sat. brine (20 mL).  The organic layer was 
transferred to an Erlenmeyer flask and dried over MgSO4, vacuum filtered, and concentrated 
under reduced pressure.  The residue was purified by silica gel column chromatography (5% 
ethyl acetate/hexanes) to yield compound 3.30 as a clear oil (33 mg, 11 %).  Notebook: 02-153, 
02-157 
 
Data for 3.30 
1H NMR (500 MHz, CDCl3)  = 7.36 (s, 1 H), 6.50 (d, J = 16.0 Hz, 1 H), 6.38-6.37 (m, 1 H), 
6.31-6.30 (m, 1 H), 6.21 (dt, J = 16.0 Hz, 6.8 Hz, 1 H), 4.79 (d, J = 6.8 Hz, 2 H), 0.25 (s, 9 H). 
13C NMR (500 MHz, CDCl3)  = 153.1, 152.0, 142.9, 123.6, 120.7, 111.7, 109.6, 94.7, 94.7, 
66.3, -0.6 ppm. 
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IR (thin film) 
2961, 2175, 1712, 1657, 1489, 1253, 1216, 961, 848, 751, 705 cm-1 
HRMS (FTMS + p ESI) 
[M] calcd for C13H15O3Si: 247.0785; found, 247.0801 
TLC (5% ethyl acetate/hexanes) Rf  = 0.1 
 
 
4-(Trimethylsilyl)benzo[1,2-b:4,5-c']difuran-5(7H)-one (3.31a’).  (entry 4 Table 2) To a 0.5-
2 mL microwave vial and equipped with flea stir bar was added diene-yne (3.30, 33 mg, 0.13 
mmol) in 10% nitrobenzene/oDCB (v/v) (2.2 mL) to a final concentration of 0.06 M.  The 
solution was heated for 20 min at 225 °C and cooled to 55 °C.  The reaction solution color 
changed from yellow to dark amber.  The solution was poured directly onto silica plug, and 
solvent removed (5-20% ethyl acetate/hexanes), 3.31a’ was isolated with (10% ethyl 
acetate/hexanes) to yield a white solid (15 mg, 42 %, as a 100:0 ratio of 
benzo[b]furan:dihydrobenzo[b]furan).  Notebook: 02-156, 02-164 
 
Data for 3.31a’ 
1H NMR (500 MHz, CDCl3)  = 7.74 (d, J = 2.5 Hz, 1 H), 7.53 (s, J = 6.0 Hz, 1 H), 7.17 (d, J = 
2.5 Hz, 1 H), 5.36 (s, 2 H), 0.54 (s, 9 H). 
13C NMR (500 MHz, CDCl3)  = 171.8, 157.4, 147.0, 143.7, 136.7, 134.8, 126.0, 109.0, 105.7, 
69.0, 1.4 ppm 
IR (thin film) 
 100 
3076, 2944, 1748, 1544, 1451, 1375, 1340, 1278, 1245, 1140, 1110, 1021, 901, 874, 
843, 769, 737 cm-1 
HRMS (FTMS + p ESI)  
[M+1] calcd for C13H15O3Si: 247.0785; found 247.0798  
TLC (10% ethyl acetate/hexanes) Rf = 0.2 
 
 
(E)-3-(Thiophen-3-yl)allyl 4-cyclohexylbut-2-ynoate (3.34).  A single-necked 25 mL round-
bottomed flask equipped with a septum, magnetic stirring bar of dimension 150 mm by 100 
mm, and nitrogen inlet was flame-dried and allowed to cool.  The rubber septum was briefly 
removed, and the flask was charged with (E)-3-(thiophen-3-yl)prop-2-en-1-ol (3.04, 23 mg, 0.2 
mmol),  4-cyclohexylbut-2-ynoic acid (3.33, 28 mg, 0.2 mmol), dimethylaminopyridine (3 mg, 
0.02 mmol) and dry dichloromethane (3 mL) at rt until homogeneous.66  The septa was briefly 
removed and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (48 mg, 0.25 mmol) added in a 
single portion.  The solution was then stirred at room temperature for 16 h.  The solution was 
diluted with dichlorormethane (15 mL) and transferred to a separatory funnel.  The organics 
were washed with deionized water (2 x 20 mL) then sat. brine (20 mL).  The organic layer was 
transferred to an Erlenmeyer flask and dried over MgSO4, vacuum filtered, and concentrated 
under reduced pressure.  The residue was purified by silica gel column chromatography (25% 
ethyl acetate/hexanes) to yield compound 3.34 as a clear oil (33 mg, 68 %).  Notebook: 02-080, 
02-096 
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Data for 3.34   
1H NMR (500 MHz, CDCl3)  = 7.29-7.27 (m, 1 H), 7.22-7.21 (m, 2 H), 6.69 (d, J = 16.0 Hz, 1 
H), 6.15 (dt, J = 16.0 Hz, 6.5 Hz, 1 H), 4.77 (d, J = 6.5 Hz, 2 H), 2.23 (d, J = 7.0 Hz, 2 H), 1.83-
1.80 (m, 2 H), 1.74-1.71 (m, 2 H), 1.67-1.64 (m, 1 H), 1.59-1.54 (m, 1 H), 1.30-1.21 (m, 2 H), 
1.19-1.13 (m, 1 H) 1.06-0.98 (m, 2 H). 
13C NMR (500 MHz, CDCl3)  = 154.0, 139.1, 129.7, 126.6, 125.3, 123.7, 122.4, 89.5, 66.6, 
37.0, 33.0, 26.8, 26.4, 26.3 ppm.  
IR (thin film)  
2924, 2851, 2231, 1709, 1448, 1365, 1243, 1072, 1058, 963, 831, 864, 770, 750 cm-1   
HRMS (TOF MS ES+)  
[M] calcd for C17H20O2S: 288.1184; found, 288.1187  
TLC (25% ethyl acetate/hexanes) Rf  = 0.8  
 
 
8-(Cyclohexylmethyl)thieno[2,3-f]isobenzofuran-7(5H)-one (3.35a).  (entry 5 Table 2) To a 
0.5-2 mL microwave vial and equipped with flea stir bar was added diene-yne (3.33, 32 mg, 0.1 
mmol) in 10% nitrobenzene/oDCB (v/v) (1.8 mL) to a final concentration of 0.06 M.  The 
solution was heated for 80 min at 225 °C and cooled to 55 °C.  The reaction solution color 
changed from yellow to dark amber.  The solution was poured directly onto silica plug, and 
solvent removed (10-50% ethyl acetate/hexanes), 3.35a was isolated with (15-30% ethyl 
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acetate/hexane) to yield a clear solid (23 mg, 71%, as a 99:1 ratio of 
benzo[b]thiophene:dihydrobenzo[b]thiophene).  Notebook: 02-101, 02-102, 02-103  
 
Data for 3.35a   
1H NMR (500 MHz, CDCl3)  = 7.71 (d, J = 5.5 Hz, 1 H), 7.69 (s, 1 H), 7.41 (d, J = 5.5 Hz, 1 
H), 5.34 (s, 2 H), 3.31 (d, J = 7.5 Hz, 2 H), 1.94-1.89 (m, 1 H), 1.68-1.61 (m, 5 H), 1.24-1.14 
(m, 5 H).  
H2O impurity 1.55; Ethyl acetate impurity 4.12, 2.05, 1.2 ppm  
13C NMR (500 MHz, CDCl3)  = 171.2, 144.1, 142.8, 142.1, 139.2, 131.6, 124.3, 119.1, 114.4, 
68.6, 39.4, 38.1, 33.7, 26.7, 26.6 ppm  
IR (thin film)  
3103, 2922, 2849, 1746, 1606, 1499, 1447, 1344, 1322, 1263, 1209, 1161, 1092, 1064, 
1013, 940, 892, 859, 828, 803, 737, 706 cm-1  
HRMS (FTMS + p ESI)  
[M+1] calcd for C17H19O2S: 287.1100; found 287.1096   
TLC (25% ethyl acetate/hexanes) Rf = 0.5 
 
 
4a,5-Dihydrothieno[2,3-f]isobenzofuran-7(4H)-one (3.35b).  (entry 6 Table 3) To a 0.5-2 mL 
microwave vial and equipped with flea stir bar was added diene-yne (3.34, 31 mg, 0.1 mmol) in 
DMF (1.76 mL) to a final concentration of 0.06 M.  The solution was heated for 3 min at 225 
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°C and cooled to 55 °C.  The reaction solution color changed from clear to amber.  The solution 
was diluted with 20 mL ethyl acetate and washed 3 x 20 mL deionized water.  The organics 
were collected and dried with MgSO4, filtered and concentrated under reduced pressure to yield 
brown oil.  The residue was purified by silica gel column chromatography (20% ethyl 
acetate/hexanes), to yield 3.35b a white waxy solid (23 mg, 71%, as a 7:93 ratio of 
benzo[b]thiophene:dihydrobenzo[b]thiophene).  Notebook: 02-130, 02-133  
 
Data for 3.35b   
1H NMR (500 MHz, CDCl3)  = 7.38 (d, J = 5.0 Hz, 1 H), 6.95 (d, J = 5.0 Hz, 1 H), 4.64 (t, J = 
8.9 Hz, 1 H), 3.96 (t, J = 8.9 Hz, 1 H), 3.39-3.29 (m, 1 H), 3.09-3.01 (m, 2 H), 2.79-2.73 (m, 1 
H), 2.50 (t, J = 15.9 Hz, 1 H), 2.04-1.62 (m, 6 H), 1.28-1.14 (m, 5 H).  
Note: 3.35a impurity (d, 7.71), (s, 7.69), (d, 7.41), (s, 5.34), (d, 3.31); 
H2O impurity 1.56 ppm; H grease 1.26, 0.83 ppm; silicon grease 0.07 ppm 
13C NMR (500 MHz, CDCl3)  =169.8, 144.6, 139.3, 138.7, 128.0, 127.8, 117.9, 71.3, 38.8, 
37.2, 37.1, 33.7, 33.4, 28.8, 26.7, 26.7, 26.5 ppm  
IR (thin film)  
3098, 2922, 2849, 1732, 1626, 1512, 1447, 1420, 1372, 1339, 1270, 1225, 1170, 1073, 
1045, 1008, 985, 936, 910, 838, 735 cm-1  
HRMS (FTMS + p ESI) 
[M+1] calcd for C17H21O2S: 289.1257; found 289.1251 
TLC (25% ethyl acetate/hexanes) Rf = 0.5 
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(E)-3-(3-Bromoprop-1-en-1-yl)thiophene.  A single-necked 25 mL round-bottomed flask 
equipped with a septum, magnetic stirring bar of dimension 150 mm by 100 mm, and nitrogen 
inlet was flame-dried and allowed to cool.  The rubber septum was briefly removed, and the 
flask was charged with (E)-3-(thiophen-3-yl)prop-2-en-1-ol (3.04, 201 mg, 1.4 mmol) and 
diethyl ether (11 mL) at rt.  The solution was cooled to 0 °C (bath temperature) in an ice bath, 
and phosphorus tribromide (126 mg, 0.6 mmol) in diethyl ether (1 mL) was added drop wise via 
syringe (approximately 1 min).  After 1.5 h at 0 °C, the reaction was poured to a separatory 
funnel, and washed with sat. sodium bicarbonate (15 mL). The organic layer was transferred to 
an Erlenmeyer flask and the aqueous layer extracted with diethyl ether (3 x 15 mL).  The 
organics were combined and dried over MgSO4, vacuum filtered, and concentrated under 
reduced pressure to yield a yellow oil.  The product was used directly without purification in the 
next step.  Notebook: 02-068, 02-099 
 
Data for (E)-3-(3-Bromoprop-1-en-1-yl)thiophene     
1H NMR (500 MHz, CDCl3)  = 7.30-7.28 (m, 1 H), 7.22-7.21 (m, 3.2 Hz, 2 H), 6.66 (d, J = 
15.5 Hz, 1 H), 6.25 (dt, J = 15.5 Hz, 7.8 Hz, 1 H), 4.14 (d, J = 7.8 Hz, 2 H).  
H2O impurity 1.54 ppm  
13C NMR (500 MHz, CDCl3)  = 138.8, 129.0, 126.7, 125.4, 125.3, 123.9, 33.9 ppm.  
IR (thin film)  
2150, 1642, 1454 cm-1 
TLC (10% diethyl ether/hexanes) Rf  = 0.7 
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(E)-2-(3-(Thiophen-3-yl)allyl)isoindoline-1,3-dione (3.36).  A single-necked 50 mL round-
bottomed flask equipped with a septum, magnetic stirring bar of dimension 150 mm by 100 
mm, and nitrogen inlet was flame-dried and allowed to cool.  (E)-3-(3-Bromoprop-1-en-
1yl)thiophene (290 mg, 1.4 mmol) in dimethylformamide (1 mL) at rt was added to the flask.  
The rubber septum was briefly removed and potassium phthalimide (593 mg, 3.2 mmol) added 
in a single portion followed by dimethylformamide (9 mL).60  The reaction was stirred at room 
temperature for 24 h.  The solvent was removed under reduced pressure to yield a tan solid.  
The residue was solvated in ethyl acetate and passed through a silica gel plug (ethyl acetate).  
The resulting solution was concentrated under reduced pressure to yield compound 3.36 as a 
beige solid then recrystallized in ethyl acetate to yield white solid (320 mg, 83% yield over 2 
steps).  Notebook: 02-069, 02-082  
 
Data for 3.36    
1H NMR (500 MHz, CDCl3)  = 7.87-7.86 (m, 2 H), 7.73-7.72 (m, 2 H), 7.25-7.23 (m, 1 H), 
7.17-7.16 (m, 2 H), 6.68 (d, J = 15.8 Hz, 1 H), 6.11 (dt, J = 15.8 Hz, 6.5 Hz, 1 H), 4.41 (d, J = 
6.5 Hz, 2 H).   
H2O impurity 1.54 ppm  
13C NMR (400 MHz, CDCl3)  = 168.3, 139.3, 134.4, 132.6, 128.5, 126.5, 125.3, 123.7, 123.2, 
123.0, 40.0 ppm  
IR (thin film) 
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1703, 1469, 1427, 1397, 1108, 954, 861,830,800, 750, 717 cm-1  
HRMS (FTMS + p ESI)  
[M+1] calcd for C15H12O2NS: 270.0583; found, 270.0589  
TLC (30% ethyl acetate/hexanes) Rf  = 0.45 
 
 
(E)-3-(Thiophen-3-yl)prop-2-en-1-amine (3.37).  A double-necked 100 mL round-bottomed 
flask equipped with a septum, magnetic stirring bar of dimension 150 mm by 100 mm, and 
nitrogen inlet was flame-dried and allowed to cool then attached to refluxing column.  (E)-2-
(3(thiophen-3-yl)allyl)isoindoline-1,3-dione (3.36, 320 mg, 1.2 mmol) in ethanol (10 mL) at rt 
was added to the flask through the side neck.   Hydrazine monohydrate (0.3 mL, 5.9 mmol) was 
added dropwise through the side neck followed by ethanol (10 mL).60  The solution was 
refluxed for 3 h and allowed to cool to rt.  The contents were dissolved in a (1:1) H2O:CH3OH 
(60 mL) solution and the contents added to a separatory funnel.  The product was then extracted 
with dichloromethane (5 x 20 mL).  The organics were combined and dried over MgSO4, 
vacuum filtered, and concentrated under reduced pressure to yield a yellow oil.  The resulting 
solution was concentrated under reduced pressure to yield compound 3.37 as a yellow oil (140 
mg, 100% crude yield).  The product was used without further purification in the next step.  
Notebook: 02114, 02-121  
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Data for 3.37 
1H NMR (300 MHz, CDCl3)  = 7.28-7.25 (m, 1 H), 7.21-7.19 (m, 1 H), 7.11 (s, 1 H) 6.52 (d, J 
= 15.9 Hz, 1 H), 6.18 (dt, J = 15.9 Hz, 5.8 Hz, 1 H), 3.45 (d, J = 5.8 Hz, 2 H) 
H2O impurity 1.42 ppm, Grease impurity 1.26 ppm 
13C NMR (500 MHz, CDCl3)  = 140.1, 131.6, 126.3, 125.3, 124.1, 121.7 ppm 
IR (thin film) 
3369, 2254, 2127, 1658, 1474, 1376, 1322, 1025, 825, 764 cm-1  
HRMS (FTMS + p ESI) 
[M+1] calcd for C7H10NS: 140.0528; found 140.0532  
TLC (Methanol) Rf  = 0.01 
 
 
(E)-N-(3-(Thiophen-3-yl)allyl)-3-(trimethylsilyl)propiolamide (3.38).  A single-necked 10 
mL round-bottomed flask equipped with a septum, magnetic stirring bar of dimension 150 mm 
by 100 mm, and nitrogen inlet was flame-dried and allowed to cool.  The rubber septum was 
briefly removed, and the flask was charged with 3-phenylpropiolic acid (3.05, 95 mg, 0.6 
mmol), and tetrahydrofuran (4 mL) at rt.  The solution was cooled to 0 °C (bath temperature) in 
an ice bath.  Once cooled, dimethyformamide (4 drops, 21 guage needle) was added dropwise.  
This was followed by dropwise addition of oxalyl chloride (60 L, 0.7 mmol) causing vigorous 
gas evolution.61  The solution was stirred at 0 °C for 2 h then briefly removed from the ice bath 
and placed under vacuum to remove excess oxalyl chloride.  The residue was dissolved in 
diethyl ether (1ml), cooled to 0 °C, and (E)-3-(thiophen-3-yl)prop-2-en-1-amine (3.37, 71 mg, 
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0.5 mmol) solvated in dichloromethane (0.5 mL) was added dropwise via syringe.  After 2 h, 
the reaction was quenched with 5% hydrochloric acid (15 mL) and transferred to a separatory 
funnel.  The aqueous layer washed with diethyl ether (3 x 20 mL).  The organic layer was 
transferred to an Erlenmeyer flask and dried over MgSO4, vacuum filtered, and concentrated 
under reduced pressure.  The residue was purified by silica gel column chromatography (10-
30% ethyl acetate/hexanes) to yield compound 3.38 as a clear yellow solid (43 mg, 25%).  
Notebook: 02-106  
  
Data for 3.38   
1H NMR (500 MHz, CDCl3)  = 7.55-7.52 (m, 2 H), 7.43-7.36 (m, 3 H), 7.28-7.27 (m, 1 H), 
7.21-7.20 (m, 1 H), 7.18-7.17 (m, 1 H), 6.61 (d, J = 16.0 Hz, 1 H), 6.10 (dt, J = 16.0 Hz, 6.2 Hz, 
1 H), 6.06 (b s, 1 H), 4.12 (t, J = 6.2 Hz, 2 H). 
H2O impurity 1.56 ppm, Grease impurity 1.26 ppm, Unknown impurity 3.40, 2.73, 1.94 ppm 
13C NMR (400 MHz, CDCl3)  = 153.5, 139.2, 132.9, 132.8, 130.4, 128.9, 128.8, 127.4, 126.5, 
125.2, 124.5, 122.8, 120.4, 42.2 ppm.  
IR (thin film)  
3269, 3056, 2920, 2219, 1629, 1537, 1300, 1216, 1085, 963, 757, 689 cm-1   
HRMS (FTMS + p ESI)  
[M+1] calcd for C16H14ONS: 268.0791; found, 268.0793  
TLC (20% ethyl acetate/hexanes) Rf  = 0.3 
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8-Phenyl-5,6-dihydro-7H-thieno[2,3-f]isoindol-7-one (3.39a).  (entry 6 Table 2) To a 0.5-2 
mL microwave vial and equipped with flea stir bar was added diene-yne (3.38, 30 mg, 0.1 
mmol) in 10% nitrobenzene/oDCB (v/v) (1.5 mL) to a final concentration of 0.06 M.  The 
solution was heated for 30 min at 225 °C and cooled to 55 °C.  The reaction solution color 
changed from yellow to dark amber.  The solution was poured directly onto silica plug, and 
solvent removed (10-40% ethyl acetate/hexanes), 3.39a was isolated with (50% ethyl 
acetate/hexanes) to yield a white solid (24 mg, 82 %, as a 95:5 ratio of 
benzo[b]thiophene:dihydrobenzo[b]thiophene).  Notebook: 02-079, 02-108  
 
Data for 3.39a   
1H NMR (500 MHz, CDCl3)  = 7.85 (s, 1 H), 7.63-7.60 (m, 3 H), 7.52-7.44 (m, 4 H), 6.19 (b s, 
1 H), 4.53 (s, 2 H).  
H2O impurity 1.54 ppm; Ethyl Acetate 4.12, 2.05, 1.2 ppm  
13C NMR (500 MHz, CDCl3)  = 172.4, 146.7, 141.9, 139.9, 134.7, 133.8, 130.3, 123.2, 119.2, 
45.0 ppm  
IR (thin film)  
3225, 2985, 2926, 1742, 1691, 1607, 1554, 1464, 1374, 1243, 1047, 914, 745 cm-1  
HRMS (FTMS + p ESI)  
[M+1] calcd for C16H12ONS: 266.0634; found 266.0642 
TLC (50% ethyl acetate/hexanes) Rf = 0.4 
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(E)-N-(3-(Thiophen-3-yl)allyl)-3-(trimethylsilyl)propiolamide (3.40).  A single-necked 25 
mL round-bottomed flask equipped with a septum, magnetic stirring bar of dimension 150 mm 
by 100 mm, and nitrogen inlet was flame-dried and allowed to cool.  The rubber septum was 
briefly removed, and the flask was charged with 3-(trimethylsilyl)propiolic acid (3.25, 126 mg, 
0.9 mmol), and tetrahydrofuran (3 mL) at rt.  The solution was cooled to 0 °C (bath 
temperature) in an ice bath.  Once cooled, dimethyformamide (4 drops, 21 guage needle) was 
added dropwise.61  This was followed by dropwise addition of oxalyl chloride (80 L, 1.0 
mmol) causing vigorous gas evolution.  The solution was stirred at 0 °C for 2.5 hours then 
briefly removed from the ice bath and placed under vacuum to remove excess oxalyl chloride.  
The residue was placed back into the ice bath and (E)-3-(thiophen-3-yl)prop-2-en-1-amine 
(3.37, 139 mg, 1.0 mmol) solvated in dichloromethane (0.5 mL) was added dropwise via 
syringe and stirred overnight.  The reaction was quenched with 5% hydrochloric acid (15 mL) 
and transferred to a separatory funnel.  The aqueous layer washed with diethyl ether (3 x 20 
mL).  The organic layer was transferred to an Erlenmeyer flask and dried over MgSO4, vacuum 
filtered, and concentrated under reduced pressure.  The residue was purified by silica gel 
column chromatography (10-30% ethyl acetate/hexanes) to yield compound 3.40 as a clear 
yellow oil (76 mg, 32%).  Notebook: 02-075, 02-116  
 
Data for 3.40 
1H NMR (500 MHz, CDCl3)  = 7.28-7.27 (m, 1 H), 7.19-7.16 (m, 2 H), 6.56 (d, J = 16.0 Hz, 1 
H), 6.03 (dt, J = 16.0 Hz, 6.5 Hz, 1 H), 5.93 (b s, 1 H), 4.04 (t, J = 6.5 Hz, 2 H), 0.23 (s, 9 H).  
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Z Amide Isomer 5.79 (b s), 4.18 (t), 0.25 (s)  
13C NMR (500 MHz, CDCl3)  = 152.9, 139.3, 127.6, 126.6, 125.3, 124.5, 122.9, 97.8, 92.1, 
42.1, -0.3 ppm.  
IR (thin film)  
3101, 2959, 2170, 1707, 1635, 1536, 1251, 1083, 963, 848, 763 cm-1   
HRMS (FTMS + p ESI)  
[M+1] calcd for C13H18ONSSi: 264.0873; found, 264.0879  
TLC (20% ethyl acetate/hexanes) Rf  = 0.4 
 
 
8-(Trimethylsilyl)-5,6-dihydro-7H-thieno[2,3-f]isoindol-7-one (3.41a).  (entry 7 Table 2) To 
a 0.5-2 mL microwave vial and equipped with flea stir bar was added diene-yne (3.40, 30 mg, 
0.11 mmol) in 10% nitrobenzene/oDCB (v/v) (1.6 mL) to a final concentration of 0.06 M.  The 
solution was heated for 30 min at 225 °C and cooled to 55 °C.  The reaction solution color 
changed from yellow to dark amber.  The solution was poured directly onto silica plug, and 
solvent removed (10-40% ethyl acetate/hexanes), 3.40a was isolated with (30% ethyl 
acetate/hexanes) to yield a yellow solid (22.4 mg, 74 %, as a 99:1 ratio of 
benzo[b]thiophene:dihydrobenzo[b]thiophene).  Notebook: 02-109, 02-120  
  
Data for 3.41a   
1H NMR (500 MHz, CDCl3)  = 7.87 (s, 1 H), 7.64 (d, J = 5.5 Hz, 1 H), 7.38 (d, J = 5.5 Hz, 1 
H), 6.01 (b s, 1 H), 4.50 (s, 2 H), 0.61 (s, 9 H).  
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H2O impurity 1.54 ppm  
13C NMR (500 MHz, CDCl3)  = 172.5, 146.6, 141.8, 139.8, 134.5, 133.9, 130.1, 123.1, 119.1, 
45.0, 2.5 ppm  
IR (thin film)  
3193, 3086, 1691, 1597, 1460, 1350, 1264, 1236, 1115, 1082, 998, 897, 847, 742, 684, 
cm-1  
HRMS (FTMS + p ESI)  
[M+1] calcd for C13H16ONSSi:262.0716; found 262.0721  
TLC (30% ethyl acetate/hexanes) Rf = 0.4 
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A.4 COMPOUND 1H AND 13C NMR SPECTRA 
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